10-Q/A 1 mxwlq3201210qa.htm 10-Q/A MXWL Q3 2012 10Q/A
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
 
 
FORM 10-Q/A
(Amendment No. 1)
 
 
(Mark One)
x
QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarter ended September 30, 2012
OR
¨
TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from              to             
Commission file number 1-15477
 
 
MAXWELL TECHNOLOGIES, INC.
(Exact name of registrant as specified in its charter) 
 
Delaware
 
95-2390133
(State or other jurisdiction of
incorporation or organization)
 
(I.R.S. Employer
Identification No.)
 
 
 
3888 Calle Fortunada, San Diego, California
 
92123
(Address of principal executive offices)
 
(Zip Code)
(858) 503-3200
(Registrant’s telephone number, including area code) 
 
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    YES  x    NO  ¨
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    YES  x    NO  ¨
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer or a smaller reporting company. See definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
 
¨
  
Accelerated filer
 
x
 
 
 
 
 
 
 
Non-accelerated filer
 
¨  (Do not check if a smaller reporting company)
  
Smaller reporting company
 
¨
Indicate by check mark whether the registrant is a shell Company (as defined in Rule 12b-2 of the Act).    YES  ¨    NO  x
The number of shares of the registrant’s Common Stock outstanding as of October 19, 2012 is 29,182,923 shares.



TABLE OF CONTENTS
MAXWELL TECHNOLOGIES, INC.
INDEX TO QUARTERLY REPORT ON FORM 10-Q
For the quarter ended September 30, 2012
 
 
 
Page
 
 
 
 
 
 
 
 
 
Item 1.
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Item 2.
 
 
 
Item 3.
 
 
 
Item 4.
 
 
 
 
 
 
Item 1.
 
 
 
Item 1A.
 
 
 
Item 5.
 
 
 
Item 6.
 
 
 

2


Explanatory Note

We ("Maxwell Technologies, Inc.", the "Company") are filing this Amendment No. 1 to our Quarterly Report on Form 10-Q (the “Amended Filing”) for the quarter ended September 30, 2012, originally filed with the Securities and Exchange Commission (the “SEC”) on October 30, 2012 (the “Original Filing”), to amend and restate our unaudited financial statements and related disclosures for the periods ended September 30, 2012 and 2011 and amend certain other information as indicated below. This Amended Filing is filed following the restatement of our financial statements for the first three quarters of the fiscal year ended December 31, 2012, for the fiscal year ended December 31, 2011, and for each of the interim periods within the fiscal year ended December 31, 2011, in our Annual Report on Form 10-K for the fiscal year ended December 31, 2012 filed on August 1, 2013, for purposes of maintaining compliance with certain rules of the SEC that require an issuer to have filed all required reports (including amendments to reports) during the preceding 12 months. The information in this Amended Filing regarding the restatement for the periods ended September 30, 2012 and 2011 is consistent with the information in the 2012 Form 10-K regarding the restatement of those periods. The details of the restatement are discussed below and in Note 2 to the accompanying restated consolidated financial statements.
In this Amended Filing, we are:
restating our Consolidated Balance Sheets as of September 30, 2012 and December 31, 2011, our Consolidated Statements of Operations and Comprehensive Income (Loss) for the three and nine months ended September 30, 2012 and 2011, our Consolidated Statements of Cash Flows for the nine months ended September 30, 2012 and 2011, and the Notes to our Condensed Consolidated Financial Statements;
amending our Part I, Item 2, Management's Discussion and Analysis of Financial Condition and Results of Operations, as it relates to the three and nine months ended September 30, 2012 and 2011; and
amending our Part I, Item 4, disclosure regarding Controls and Procedures.
Unless required as a result of the restatement, we have not otherwise updated or amended the information in this Amended Filing.
Background on the Restatement

Audit Committee's Investigation
In January 2013, following receipt of information concerning potential revenue recognition issues, the Audit Committee of the Board of Directors engaged independent legal counsel and forensic accountants to conduct an investigation concerning the potential issues and to work with management to determine the potential impact on accounting for revenue. In February 2013, as a result of the findings of the Audit Committee's investigation to date, the Company determined that certain of its employees had engaged in conduct which resulted in revenue being recorded in periods prior to the criteria for revenue recognition under U.S. generally accepted accounting principles being satisfied.
The investigation revealed arrangements with three of the Company's distributors regarding extended payment terms, which allowed these distributors to pay the Company after they received payment from their customer, and with one of the Company's distributors regarding return rights and profit margin protection, for sales to such distributors with respect to certain transactions. In addition, arrangements were revealed with one non-distributor customer to honor transfer of title at a date later than the customer's purchase orders indicated. Based on the results of its investigation, the Audit Committee determined that these arrangements had not been communicated to the Company's finance and accounting department, or to the Company's CEO, and therefore, had not been considered when revenue was originally recorded. Based on the terms of the agreements with these customers as they were known to the Company's finance and accounting department, it had been the Company's policy to record revenue related to shipments as title passed at either shipment from the Company's facilities or receipt at the customer's facility, assuming all other revenue recognition criteria had been achieved. In addition to the arrangements noted above, the investigation uncovered an error on an individual transaction where a customer was given extended payment terms, which allowed them to pay the Company after they received payment from their customer, but those terms were not considered when revenue was originally recognized.
As a result of the arrangements discovered during the investigation, the Company does not believe that a fixed or determinable sales price existed at the time of shipment, nor was collection reasonably assured, at least with respect to certain transactions. In addition, revenue related to certain shipments to the one non-distributor customer was recorded before the actual transfer of title and the satisfaction of the Company's obligation to deliver the products. Therefore, revenue from these sales should not have been recognized at the time of shipment.
Based on the arrangements with customers revealed in the investigation that were not considered when revenue was originally recognized, the Company determined the following:
Beginning in the period in which the investigation revealed arrangements regarding extended payment terms for certain sales to three distributors, the Company determined it is appropriate to defer revenue recognition on all sales to



these distributors from the period of shipment to the period in which payment is received. For these distributors, revenue recognition in the period in which payment is received was determined to be appropriate beginning in the fourth quarter of 2011.
Beginning in the period in which the investigation revealed return rights and profit margin protection for one distributor, the Company determined it appropriate to defer revenue recognition on all sales to this distributor until the distributor confirms with the Company that they are not entitled to any further returns or credits. For this distributor, the deferral of revenue on this basis was determined to be appropriate beginning in the fourth quarter of 2011. At such time as the distributor confirms with the Company that they are not entitled to any further returns or credits, which is currently anticipated to occur in the second half of the fiscal year 2013, previous sales for which revenue has been deferred, net of any credits or returns that may be made by the distributor, will be recognized as revenue.
For the arrangements with the non-distributor customer to honor transfer of title at a date later than the customer's purchase order indicated, the Company determined it appropriate to defer revenue recognition to the period in which the Company agreed to honor transfer of title.
For the individual transaction where a customer was given extended payment terms which were not considered when revenue was originally recognized in the first quarter of 2011, revenue recognition in the period in which payment was received, which was in the second quarter of 2011, was determined to be appropriate.

Management's Subsequent Internal Review
Once the audit committee investigation was complete, management of the Company conducted a review beginning with the first quarter of 2009 through the first quarter of 2013 to ensure that all sales arrangements had been detected and accounted for appropriately. During this review, the Company noted that there were a number of quarter end revenue cut-off errors wherein revenue was recorded prior to the transfer of title to the customer and the satisfaction of the Company's obligation to deliver the products. The Company has corrected these errors occurring in the first quarter of 2011 through the third quarter of 2012 by moving the revenue recognition for these items to the period in which delivery actually occurred.

Results of the Audit Committee's Investigation and Management's Internal Review
Based on the findings of the investigation, as previously reported in the Company's current report on Form 8-K dated March 7, 2013, the Audit Committee, in consultation with management and the Board of Directors, concluded that the Company's previously issued financial statements contained in its annual report on Form 10-K for the year ended December 31, 2011, and the quarterly reports on Form 10-Q for the quarters ended March 31, 2011, June 30, 2011, September 30, 2011, March 31, 2012, June 30, 2012 and September 30, 2012, should no longer be relied upon. Accordingly, the consolidated financial statements for the first three quarters of the fiscal year ended December 31, 2012, for the fiscal year ended December 31, 2011, and for each of the interim periods within the fiscal year ended December 31, 2011, have been restated in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2012. See Note 15, in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2012, for the effects of the restatement adjustments on our 2012 and 2011 unaudited quarterly financial information.
As a result of the Audit Committee's investigation, certain employees were terminated and the Company's Sr. Vice President of Sales and Marketing resigned as reported in the Company's current report on Form 8-K dated March 7, 2013. In connection with the errors identified during the investigation resulting in the restatement of previously reported financial statements, the Company identified control deficiencies in its internal control over financial reporting that constitute material weaknesses. For a discussion of our disclosure controls and procedures and the material weaknesses identified, see Part I, Item 4, Controls and Procedures, of this Quarterly Report on Form 10-Q/A.
The Company's previously filed annual report on Form 10-K for the fiscal year ended December 31, 2011, and its quarterly reports on Form 10-Q for the periods affected by the restatements, have not been amended, other than this amended quarterly report on Form 10-Q for the quarter ended September 30, 2012. Accordingly, investors should no longer rely upon the Company's previously released financial statements for any quarterly or annual periods after and including March 31, 2011, and any earnings releases or other communications relating to these periods. See Note 2, Restatement of Previously Issued Financial Statements and Financial Information, and Note 15, Unaudited Quarterly Financial Information, of the Notes to the Consolidated Financial Statements, in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2012, for the impact of these adjustments for the full fiscal year ended December 31, 2011, and the first three quarters of the fiscal year ended December 31, 2012 and each of the quarterly periods in the fiscal year ended December 31, 2011, respectively.

Restatement Adjustments
Restatement Adjustments Related to Sales Arrangements



Several adjustments were made to the Company's previously filed consolidated financial statements as a result of the restatement in order to reflect revenue recognition in the appropriate periods as discussed above. Accordingly, for the subject sales transactions, revenue and accounts receivable balances were reduced by an equivalent amount in the period that the sale was originally recorded as revenue, and revenue was increased in the subsequent period in which the criteria for revenue recognition were met. Further, for the subject sales transactions, cost of revenue was reduced, and inventory was increased, in the period that the sale was originally recorded as revenue, and cost of revenue was increased, and inventory was reduced, in the period the sale was ultimately recorded as revenue. However, for sales to one distributor in which revenue is being deferred until the Company determines that the distributor is not entitled to any further returns or credits, as discussed above, the increase to revenue, and the related reduction to inventory and increase to cost of revenue, will be recorded in a future period when this determination is made.
The adjustments also reflect the impacts of adjusting the Company's returns reserves for certain stock rotation rights of the distributors, and adjusting the Company's reserves for allowances for doubtful accounts, as well as commissions expense, although these changes were not material.
In addition to the adjustments to revenue, accounts receivable, inventory and cost of revenue, inventory reserve balances and cost of revenue were adjusted in relation to the adjustments to inventory discussed above, in order to reflect inventory ultimately recorded on our balance sheets at its lower of cost or market value.

Other Restatement Adjustments
Since the Company's determination to restate its previously issued financial statements constituted an event of default under the terms of its credit facility, the bank had the right to require immediate payment of the outstanding borrowings. As a result restatement adjustments were recorded to reclassify the amounts outstanding under the credit facility from long-term debt to current liabilities as of each respective balance sheet date. In addition, an insignificant amount of debt issuance costs were reclassified from a long-term asset to a short-term asset, consistent with the classification of the related debt. In June 2013, the Company entered into a forbearance agreement with the bank wherein the bank agreed to forbear from further exercise of its rights and remedies to call our outstanding debt under the credit facility in connection with the events of default for a period terminating on the earlier of September 30, 2013 or the occurrence of any additional events of default.
Further, a restatement adjustment was made to reclassify a legal settlement with a customer from selling, general and administrative expense to contra-revenue in the second quarter of 2011 in the amount of for $2.6 million. Certain other immaterial adjustments were made in connection with the restatement.
The restatement adjustments did not impact the Company's previously reported tax provision or benefit in any of the affected periods, other than a $54,000 decrease in the income tax provision for the quarter ended September 30, 2012, as all of the restatement adjustments were related to our U.S. operations, for which the Company has significant net operating loss carryforwards and has not recorded an income tax expense or benefit in any period to date. However, the restatement adjustments did impact the composition of the Company's deferred tax assets and liabilities as of December 31, 2011 as presented in Note 10, Income Taxes, of the Notes to the Consolidated Financial Statements included in the Annual Report on Form 10-K for the fiscal year ended December 31, 2012.
For the impact of the restatement adjustments on our financial statements for the three and nine months ended September 30, 2012, and 2011, see Note 2, Restatement of Previously Issued Financial Statements and Financial Information.

PART I – Financial Information
 
Item 1.
Financial Statements
The following restated condensed consolidated balance sheet as of December 31, 2011, which has been derived from restated audited financial statements, and the restated unaudited interim condensed consolidated financial statements, consisting of the condensed consolidated balance sheet as of September 30, 2012, the condensed consolidated statements of operations and statements of comprehensive income (loss) for the three and nine months ended September 30, 2012 and 2011, and the condensed consolidated statements of cash flows for the nine months ended September 30, 2012 and 2011, have been prepared in accordance with the rules and regulations of the Securities and Exchange Commission (“SEC”). Certain information and disclosures normally included in annual financial statements prepared in accordance with generally accepted accounting principles have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading.
The following restated condensed consolidated balance sheet as of December 31, 2011, which has been derived from restated audited financial statements, does not include all of the information and footnotes included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2011. In addition, the condensed consolidated financial statements for the first three quarters of the fiscal year ended December 31, 2012, for the fiscal year ended December 31, 2011, and for each of the interim periods within the fiscal year ended December 31, 2011, have been restated in the Company's Annual Report on



Form 10-K for the fiscal year ended December 31, 2012. Therefore, it is suggested that these restated condensed financial statements be read in conjunction with the financial statements and the notes thereto included in the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2012.
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenues and expenses during the reported period. Actual results could differ materially from those estimates.
In the opinion of management, these unaudited statements contain all adjustments (consisting of normal recurring adjustments, except as otherwise indicated) necessary for a fair presentation for the periods presented as required by Regulation S-X, Rule 10-01.
In addition, operating results for the three and nine months ended September 30, 2012 are not necessarily indicative of the results that may be expected for any subsequent period.

6


MAXWELL TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED BALANCE SHEETS
(in thousands, except per share data)
(Unaudited)
 
 
 
September 30, 2012
 
December 31, 2011
 
 
(Restated)
 
(Restated)
ASSETS
 
 
 
 
Current assets:
 
 
 
 
Cash and cash equivalents
 
$
20,073

 
$
29,289

Trade and other accounts receivable, net of allowance for doubtful accounts of $341 and $450 at September 30, 2012 and December 31, 2011, respectively
 
38,816

 
27,973

Inventories
 
43,802

 
33,234

Prepaid expenses and other current assets
 
2,975

 
3,152

Total current assets
 
105,666

 
93,648

Property and equipment, net
 
35,806

 
28,541

Intangible assets, net
 
758

 
1,111

Goodwill
 
24,826

 
24,887

Pension asset
 
6,945

 
6,359

Other non-current assets
 
38

 
200

Total assets
 
$
174,039

 
$
154,746

LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
 
Current liabilities:
 
 
 
 
Accounts payable and accrued liabilities
 
$
31,989

 
$
36,100

Accrued warranty
 
244

 
258

Accrued employee compensation
 
5,025

 
6,343

Deferred revenue
 
5,149

 
1,042

Short-term borrowings and current portion of long-term debt
 
9,844

 
5,431

Deferred tax liability
 
499

 
499

Total current liabilities
 
52,750

 
49,673

Deferred tax liability, long-term
 
962

 
933

Long-term debt, excluding current portion
 
25

 
68

Other long-term liabilities
 
699

 
3,028

Total liabilities
 
54,436

 
53,702

Commitments and contingencies (Note 11)
 


 


Stockholders’ equity:
 
 
 
 
Common stock, $0.10 par value per share, 40,000 shares authorized; 29,183 and 28,174 shares issued and outstanding at September 30, 2012 and December 31, 2011, respectively
 
2,915

 
2,815

Additional paid-in capital
 
267,069

 
252,907

Accumulated deficit
 
(161,000
)
 
(165,308
)
Accumulated other comprehensive income
 
10,619

 
10,630

Total stockholders’ equity
 
119,603

 
101,044

Total liabilities and stockholders’ equity
 
$
174,039

 
$
154,746

See accompanying notes to condensed consolidated financial statements.

7


MAXWELL TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS
(in thousands, except per share data)
(Unaudited)
 
 
 
Three Months Ended
 
Nine Months Ended
 
 
September 30,
 
September 30,
 
 
2012
 
2011
 
2012
 
2011
 
 
(Restated)
 
(Restated)
 
(Restated)
 
(Restated)
Revenue
 
$
42,713

 
$
42,030

 
$
114,755

 
$
109,800

Cost of revenue
 
24,571

 
25,200

 
66,932

 
67,740

Gross profit
 
18,142

 
16,830

 
47,823

 
42,060

Operating expenses:
 
 
 
 
 
 
 
 
Selling, general and administrative
 
7,342

 
9,605

 
25,539

 
26,759

Research and development
 
5,084

 
5,707

 
15,948

 
16,976

Total operating expenses
 
12,426

 
15,312

 
41,487

 
43,735

Income (loss) from operations
 
5,716

 
1,518

 
6,336

 
(1,675
)
Interest expense, net
 
(56
)
 
(27
)
 
(138
)
 
(88
)
Amortization of debt discount and prepaid debt costs
 
(16
)
 

 
(42
)
 
(55
)
Gain on embedded derivatives
 

 

 

 
1,086

Income (loss) from operations before income taxes
 
5,644

 
1,491

 
6,156

 
(732
)
Income tax provision
 
416

 
922

 
1,849

 
1,221

Net income (loss)
 
$
5,228

 
$
569

 
$
4,307

 
$
(1,953
)
Net income (loss) per share:
 
 
 
 
 
 
 
 
Basic
 
$
0.18

 
$
0.02

 
$
0.15

 
$
(0.07
)
Diluted
 
$
0.18

 
$
0.02

 
$
0.15

 
$
(0.07
)
Weighted average common shares outstanding:
 
 
 
 
 
 
 
 
Basic
 
28,736

 
27,733

 
28,511

 
27,564

Diluted
 
28,748

 
28,161

 
28,695

 
27,564

See accompanying notes to condensed consolidated financial statements.

8


MAXWELL TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME (LOSS)
(in thousands)
(Unaudited)
 
 
 
Three Months Ended
 
Nine Months Ended
 
 
September 30,
 
September 30,
 
 
2012
 
2011
 
2012
 
2011
 
 
(Restated)
 
(Restated)
 
(Restated)
 
(Restated)
Net income (loss)
 
$
5,228

 
$
569

 
$
4,307

 
$
(1,953
)
Other comprehensive income (loss), net of tax:
 
 
 
 
 
 
 
 
Foreign currency translation adjustment
 
718

 
(4,399
)
 
(176
)
 
1,661

Defined benefit pension plan, net of tax:
 
 
 
 
 
 
 
 
Amortization of deferred loss, net of tax provision of $8 and tax benefit of $117 for the three months ended September 30, 2012 and 2011, respectively; net of tax provision of $24 and tax benefit of $117 for the nine months ended September 30, 2012 and 2011, respectively
 
45

 
(34
)
 
138

 
117

Amortization of prior service cost, net of tax provision of $1 and tax benefit of $18 for the three months ended September 30, 2012 and 2011, respectively; net of tax provision of $5 and tax benefit of $18 for the nine months ended September 30, 2012 and 2011, respectively
 
10

 
(6
)
 
27

 
17

Other comprehensive income (loss), net of tax
 
773

 
(4,439
)
 
(11
)
 
1,795

Comprehensive income (loss)
 
$
6,001

 
$
(3,870
)
 
$
4,296

 
$
(158
)
See accompanying notes to condensed consolidated financial statements.

9


MAXWELL TECHNOLOGIES, INC.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(in thousands)
(Unaudited)
 
 
 
Nine Months Ended
 
 
September 30,
 
 
2012
 
2011
 
 
(Restated)
 
(Restated)
OPERATING ACTIVITIES:
 
 
 
 
Net income (loss)
 
$
4,307

 
$
(1,953
)
Adjustments to reconcile net income (loss) to net cash used in operating activities:
 
 
 
 
Depreciation
 
5,104

 
4,335

Amortization of intangible assets
 
351

 
422

Amortization of debt discount and prepaid debt costs
 
42

 
55

Gain on embedded derivatives
 

 
(1,086
)
Pension cost
 
135

 
186

Stock-based compensation expense
 
2,561

 
2,440

Provision for (recovery of) losses on accounts receivable
 
(110
)
 
299

Changes in operating assets and liabilities:
 
 
 
 
Trade and other accounts receivable
 
(10,782
)
 
(2,594
)
Inventories
 
(10,570
)
 
(10,317
)
Prepaid expenses and other assets
 
339

 
709

Accounts payable and accrued liabilities and deferred revenue
 
29

 
5,312

Accrued employee compensation
 
723

 
954

Deferred tax liability, long term
 
(1,396
)
 

Other long-term liabilities
 
(2,326
)
 
(5,583
)
Net cash used in operating activities
 
(11,593
)
 
(6,821
)
INVESTING ACTIVITIES:
 
 
 
 
Purchases of property and equipment
 
(13,121
)
 
(10,994
)
Net cash used in investing activities
 
(13,121
)
 
(10,994
)
FINANCING ACTIVITIES:
 
 
 
 
Principal payments on long-term debt and short-term borrowings
 
(6,890
)
 
(10,254
)
Proceeds from long-term and short-term borrowings
 
11,230

 
10,047

Proceeds from sale of common stock, net of offering costs
 
10,283

 

Repurchase of shares
 
(319
)
 
(154
)
Proceeds from issuance of common stock under equity compensation plans
 
1,737

 
2,561

Release of restricted cash
 

 
8,000

Net cash provided by financing activities
 
16,041

 
10,200

Decrease in cash and cash equivalents from operations
 
(8,673
)
 
(7,615
)
Effect of exchange rate changes on cash and cash equivalents
 
(543
)
 
(1,226
)
Decrease in cash and cash equivalents
 
(9,216
)
 
(8,841
)
Cash and cash equivalents, beginning of period
 
29,289

 
39,829

Cash and cash equivalents, end of period
 
$
20,073

 
$
30,988

See accompanying notes to condensed consolidated financial statements.

10


MAXWELL TECHNOLOGIES, INC.
NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS
(Unaudited)
Unless the context otherwise requires, all references to “Maxwell,” the "Company,” "we", "us," and "our," refer to Maxwell Technologies, Inc. and its subsidiaries; all references to “Maxwell SA” refer to the Company’s Swiss subsidiary, Maxwell Technologies, SA.
Note 1 – Description of Business and Basis of Presentation
Description of Business
Maxwell Technologies, Inc. is a Delaware corporation originally incorporated in 1965 under the name Maxwell Laboratories, Inc. In 1983, the Company completed an initial public offering, and in 1996, changed its name to Maxwell Technologies, Inc. The Company is headquartered in San Diego, California, and has two manufacturing locations, in San Diego, California and Rossens, Switzerland. The Company is also in the process of opening a manufacturing facility in Peoria, Arizona. In addition, the Company has two contract manufacturers located in China. Maxwell operates as one operating segment called High Reliability, which is comprised of three product lines:
Ultracapacitors: The Company’s primary focus, ultracapacitors, are energy storage devices that possess a unique combination of high power density, extremely long operational life and the ability to charge and discharge very rapidly. The Company’s ultracapacitor cells and multi-cell packs and modules provide highly reliable energy storage and power delivery solutions for applications in multiple industries, including transportation, automotive, information technology, renewable energy and consumer and industrial electronics.
High-Voltage Capacitors: The Company’s CONDIS® high-voltage capacitors are extremely robust devices that are designed and manufactured to perform reliably for decades. These products include grading and coupling capacitors and capacitive voltage dividers that are used to ensure the safety and reliability of electric utility infrastructure and other applications involving transport, distribution and measurement of high-voltage electrical energy.
Radiation-Hardened Microelectronic Products: The Company’s radiation-hardened microelectronic products include high-performance, high-density power modules, memory modules and single board computers that incorporate our proprietary RADPAK® packaging and shielding technology and novel architectures that enable them to withstand environmental radiation effects and perform reliably in space.
The Company’s products are designed to perform reliably for the life of the products and systems into which they are integrated. The Company achieves high reliability through the application of proprietary technologies and rigorously controlled design, development, manufacturing and test processes.
Financial Statement Presentation
The accompanying condensed consolidated financial statements include the accounts of Maxwell Technologies, Inc. and its subsidiaries. All significant intercompany transactions and account balances have been eliminated in consolidation. The Company has prepared the accompanying unaudited interim condensed consolidated financial statements in accordance with the instructions to Form 10-Q and the standards of accounting measurement set forth in the Interim Reporting Topic of the Financial Accounting Standards Board (“FASB”) Accounting Standards Codification (“ASC”). Consequently, the Company has not necessarily included in this Form 10-Q/A all information and footnotes required for audited financial statements. In the opinion of the Company’s management, the accompanying unaudited condensed consolidated financial statements in this Form 10-Q/A contain all adjustments (consisting only of normal recurring adjustments, except as otherwise indicated) necessary to present fairly the financial position, results of operations, and cash flows of Maxwell Technologies, Inc. for all periods presented. The results reported in these condensed consolidated financial statements should not be regarded as necessarily indicative of results that may be expected for any subsequent period or for the entire year. These unaudited condensed consolidated financial statements and notes thereto should be read in conjunction with the Company’s audited financial statements and the notes thereto included in the Company’s latest Annual Report on Form 10-K. Certain information and footnote disclosures normally included in the annual financial statements prepared in accordance with accounting principles generally accepted in the United States (“U.S. GAAP”) have been condensed or omitted in the accompanying interim consolidated financial statements. The year-end condensed balance sheet data was derived from audited financial statements, but does not include all disclosures required by U.S. GAAP.
Unless required as a result of the restatement, as discussed in Note 2, Restatement of Previously Issued Financial Statements, the Company has not otherwise updated or amended the information in this amended quarterly report on Form 10-Q.

11


Use of Estimates
The preparation of financial statements in conformity with accounting principles generally accepted in the United States of America requires management to make estimates and assumptions that affect reported amounts and related disclosures. These estimates include, but are not limited to, assessing the collectability of accounts receivable, applied and unapplied production costs, production capacities, the usage and recoverability of inventories and long-lived assets, including deferred income taxes, the incurrence of warranty obligations, impairment of goodwill and other intangible assets, estimation of the cost to complete certain projects, accruals for estimated losses from legal matters, and estimation of the value of stock-based compensation awards, including the probability that the performance criteria of restricted stock awards will be met.
Warranty Obligation
The Company provides warranties on all product sales. The majority of the Company’s warranties are for one to two years in the normal course of business. The Company accrues for the estimated warranty costs at the time of sale based on historical warranty experience plus any known or expected changes in warranty exposure.
Net Income (Loss) per Share
In accordance with the Earnings Per Share Topic of the FASB ASC, basic net income (loss) per share is calculated using the weighted average number of common shares outstanding during the period. Diluted net income per share includes the impact of additional common shares that would have been outstanding if potentially dilutive common shares were issued. Potentially dilutive securities are not considered in the calculation of diluted net loss per share, as their inclusion would be anti-dilutive. The following table sets forth the computation of basic and diluted net income (loss) per share (in thousands, except per share data):
 
 
Three Months Ended
 
Nine Months Ended
 
 
September 30,
 
September 30,
 
 
2012
 
2011
 
2012
 
2011
 
 
(Restated)
 
(Restated)
 
(Restated)
 
(Restated)
Numerator
 
 
 
 
 
 
 
 
Net income (loss)
 
$
5,228

 
$
569

 
$
4,307

 
$
(1,953
)
Denominator
 
 
 
 
 
 
 
 
Weighted-average common shares outstanding
 
28,736

 
27,733

 
28,511

 
27,564

Effect of potentially dilutive securities:
 
 
 
 
 
 
 
 
Options to purchase common stock
 
8

 
410

 
153

 

Restricted stock awards
 
3

 
8

 
11

 

Restricted stock unit awards
 

 
10

 
3

 

Employee stock purchase plan
 
1

 

 
17

 

Weighted-average common shares outstanding, assuming dilution
 
28,748

 
28,161

 
28,695

 
27,564

Net income (loss) per share
 
 
 
 
 
 
 
 
Basic
 
$
0.18

 
$
0.02

 
$
0.15

 
$
(0.07
)
Diluted
 
$
0.18

 
$
0.02

 
$
0.15

 
$
(0.07
)
The following table summarizes instruments that may be convertible into common shares that are not included in the denominator used in the diluted net income per share calculation because to do so would be anti-dilutive (in thousands):
 
 
Three Months Ended
 
Nine Months Ended
 
 
September 30,
 
September 30,
 
 
2012
 
2011
 
2012
 
2011
Outstanding options to purchase common stock
 
920

 
344

 
549

 
1,248

Restricted stock awards
 
337

 
141

 
338

 
183

Restricted stock unit awards
 
20

 
22

 
17

 
22

Employee stock purchase plan awards
 

 

 

 
12

Change in Additional Paid in Capital

12


For the nine months ended September 30, 2012, additional paid in capital increased $14.2 million. This increase includes $10.2 million related to proceeds from shares of common stock sold pursuant to the Company’s shelf registration statement, net of offering costs, and $4.3 million associated with the Company’s stock-based compensation plans, offset by $318,000 for the repurchase of shares that were withheld by the Company to satisfy employee tax liabilities upon the vesting of restricted stock awards.
Pending Accounting Pronouncements
In December 2011, the FASB issued Accounting Standards Update No. 2011-11, Disclosures about Offsetting Assets and Liabilities, which requires companies to disclose information about financial instruments that have been offset and related arrangements to enable users of its financial statements to understand the effect of those arrangements on its financial position. In January 2013, the FASB issued Accounting Standards Update No. 2013-01, Clarifying the Scope of Disclosures about Offsetting Assets and Liabilities, which limits the scope of the new balance sheet offsetting disclosures to derivatives, repurchase agreements, and securities lending transactions to the extent that they are (1) offset in the financial statements or (2) subject to an enforceable master netting arrangement or similar agreement. Companies will be required to provide both net (offset amounts) and gross information in the notes to the financial statements for relevant assets and liabilities that are offset. These standard updates will be effective for fiscal years, and interim periods within those years, beginning on or after January 1, 2013. The Company does not expect the adoption of these standard updates to impact its financial position or results of operations, as they only require additional disclosure in the Company’s financial statements.
In July 2012, the FASB issued Accounting Standards Update No. 2012-02, Intangibles—Goodwill and Other (Topic 350): Testing Indefinite-Lived Intangible Assets for Impairment. The new guidance is intended to reduce the complexity and costs of the annual impairment test for indefinite-lived intangible assets by allowing companies to make a qualitative evaluation about the likelihood of impairment to determine whether it should perform a quantitative impairment test. This new guidance is effective for annual and interim impairment tests performed for fiscal years beginning after September 15, 2012, with early adoption permitted. The Company anticipates early adoption of this standard in the fourth quarter of 2012. The Company does not expect the adoption of the standard update to have a significant impact on its financial position or results of operations.
Note 2 – Restatement of Previously Issued Financial Statements
Background on the Restatement
Audit Committee's Investigation
In January 2013, following receipt of information concerning potential revenue recognition issues, the Audit Committee of the Board of Directors engaged independent legal counsel and forensic accountants to conduct an investigation concerning the potential issues and to work with management to determine the potential impact on accounting for revenue. In February 2013, as a result of the findings of the Audit Committee's investigation to date, the Company determined that certain of its employees had engaged in conduct which resulted in revenue being recorded in periods prior to the criteria for revenue recognition under U.S. generally accepted accounting principles being satisfied.
The investigation revealed arrangements with three of the Company's distributors regarding extended payment terms, which allowed these distributors to pay the Company after they received payment from their customer, and with one of the Company's distributors regarding return rights and profit margin protection, for sales to such distributors with respect to certain transactions. In addition, arrangements were revealed with one non-distributor customer to honor transfer of title at a date later than the customer's purchase orders indicated. Based on the results of its investigation, the Audit Committee determined that these arrangements had not been communicated to the Company's finance and accounting department, or to the Company's CEO, and therefore, had not been considered when revenue was originally recorded. Based on the terms of the agreements with these customers as they were known to the Company's finance and accounting department, it had been the Company's policy to record revenue related to shipments as title passed at either shipment from the Company's facilities or receipt at the customer's facility, assuming all other revenue recognition criteria had been achieved. In addition to the arrangements noted above, the investigation uncovered an error on an individual transaction where a customer was given extended payment terms, which allowed them to pay the Company after they received payment from their customer, but those terms were not considered when revenue was originally recognized.
As a result of the arrangements discovered during the investigation, the Company does not believe that a fixed or determinable sales price existed at the time of shipment, nor was collection reasonably assured, at least with respect to certain transactions. In addition, revenue related to certain shipments to the one non-distributor customer was recorded before the actual transfer of title and the satisfaction of the Company's obligation to deliver the products. Therefore, revenue from these sales should not have been recognized at the time of shipment.

13


Based on the arrangements with customers revealed in the investigation that were not considered when revenue was originally recognized, the Company determined the following:
Beginning in the period in which the investigation revealed arrangements regarding extended payment terms for certain sales to three distributors, the Company determined it is appropriate to defer revenue recognition on all sales to these distributors from the period of shipment to the period in which payment is received. For these distributors, revenue recognition in the period in which payment is received was determined to be appropriate beginning in the fourth quarter of 2011.
Beginning in the period in which the investigation revealed return rights and profit margin protection for one distributor, the Company determined it appropriate to defer revenue recognition on all sales to this distributor until the distributor confirms with the Company that they are not entitled to any further returns or credits. For this distributor, the deferral of revenue on this basis was determined to be appropriate beginning in the fourth quarter of 2011. At such time as the distributor confirms with the Company that they are not entitled to any further returns or credits, which is currently anticipated to occur in the second half of the fiscal year 2013, previous sales for which revenue has been deferred, net of any credits or returns that may be made by the distributor, will be recognized as revenue.
For the arrangements with the non-distributor customer to honor transfer of title at a date later than the customer's purchase order indicated, the Company determined it appropriate to defer revenue recognition to the period in which the Company agreed to honor transfer of title.
For the individual transaction where a customer was given extended payment terms which were not considered when revenue was originally recognized in the first quarter of 2011, revenue recognition in the period in which payment was received, which was in the second quarter of 2011, was determined to be appropriate.
Management's Subsequent Internal Review
Once the audit committee investigation was complete, management of the Company conducted a review beginning with the first quarter of 2009 through the first quarter of 2013 to ensure that all sales arrangements had been detected and accounted for appropriately. During this review, the Company noted that there were a number of quarter end revenue cut-off errors wherein revenue was recorded prior to the transfer of title to the customer and the satisfaction of the Company's obligation to deliver the products. The Company has corrected these errors occurring in the first quarter of 2011 through the third quarter of 2012 by moving the revenue recognition for these items to the period in which delivery actually occurred.
Results of the Audit Committee's Investigation and Management's Internal Review
Based on the findings of the investigation, as previously reported in the Company's current report on Form 8-K dated March 7, 2013, the Audit Committee, in consultation with management and the Board of Directors, concluded that the Company's previously issued financial statements contained in its annual report on Form 10-K for the year ended December 31, 2011, and the quarterly reports on Form 10-Q for the quarters ended March 31, 2011, June 30, 2011, September 30, 2011, March 31, 2012, June 30, 2012 and September 30, 2012, should no longer be relied upon. Accordingly, the consolidated financial statements for the first three quarters of the fiscal year ended December 31, 2012, for the fiscal year ended December 31, 2011, and for each of the interim periods within the fiscal year ended December 31, 2011, have been restated in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2012. See Note 15, in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2012, for the effects of the restatement adjustments on our 2012 and 2011 unaudited quarterly financial information.
As a result of the Audit Committee's investigation, certain employees were terminated and the Company's Sr. Vice President of Sales and Marketing resigned as reported in the Company's current report on Form 8-K dated March 7, 2013.
In connection with the errors identified during the investigation resulting in the restatement of previously reported financial statements, the Company identified control deficiencies in its internal control over financial reporting that constitute material weaknesses. For a discussion of our disclosure controls and procedures and the material weaknesses identified, see Part I, Item 4, Controls and Procedures, of this Quarterly Report on Form 10-Q/A.
The Company's previously filed annual report on Form 10-K for the fiscal year ended December 31, 2011, and its quarterly reports on Form 10-Q for the periods affected by the restatements, have not been amended, other than this amended quarterly report on Form 10-Q for the quarter ended September 30, 2012. Accordingly, investors should no longer rely upon the Company's previously released financial statements for any quarterly or annual periods after and including March 31, 2011, and any earnings releases or other communications relating to these periods. See Note 2, Restatement of Previously Issued

14


Financial Statements and Financial Information, and Note 15, Unaudited Quarterly Financial Information, of the Notes to the Consolidated Financial Statements, in the Company's Annual Report on Form 10-K for the fiscal year ended December 31, 2012, for the impact of these adjustments for the full fiscal year ended December 31, 2011, and the first three quarters of the fiscal year ended December 31, 2012 and each of the quarterly periods in the fiscal year ended December 31, 2011, respectively.
Restatement Adjustments
Restatement Adjustments Related to Sales Arrangements
Several adjustments were made to the Company's previously filed consolidated financial statements as a result of the restatement in order to reflect revenue recognition in the appropriate periods as discussed above. Accordingly, for the subject sales transactions, revenue and accounts receivable balances were reduced by an equivalent amount in the period that the sale was originally recorded as revenue, and revenue was increased in the subsequent period in which the criteria for revenue recognition were met. Further, for the subject sales transactions, cost of revenue was reduced, and inventory was increased, in the period that the sale was originally recorded as revenue, and cost of revenue was increased, and inventory was reduced, in the period the sale was ultimately recorded as revenue. However, for sales to one distributor in which revenue is being deferred until the Company determines that the distributor is not entitled to any further returns or credits, as discussed above, the increase to revenue, and the related reduction to inventory and increase to cost of revenue, will be recorded in a future period when this determination is made.
The adjustments also reflect the impacts of adjusting the Company's returns reserves for certain stock rotation rights of the distributors, and adjusting the Company's reserves for allowances for doubtful accounts, as well as commissions expense, although these changes were not material.
In addition to the adjustments to revenue, accounts receivable, inventory and cost of revenue, inventory reserve balances and cost of revenue were adjusted in relation to the adjustments to inventory discussed above, in order to reflect inventory ultimately recorded on our balance sheets at its lower of cost or market value.
Other Restatement Adjustments
Since the Company's determination to restate its previously issued financial statements constituted an event of default under the terms of its credit facility, the bank had the right to require immediate payment of the outstanding borrowings. As a result restatement adjustments were recorded to reclassify the amounts outstanding under the credit facility from long-term debt to current liabilities as of each respective balance sheet date. In addition, an insignificant amount of debt issuance costs were reclassified from a long-term asset to a short-term asset, consistent with the classification of the related debt. In June 2013, the Company entered into a forbearance agreement with the bank wherein the bank agreed to forbear from further exercise of its rights and remedies to call our outstanding debt under the credit facility in connection with the events of default for a period terminating on the earlier of September 30, 2013 or the occurrence of any additional events of default.
Further, a restatement adjustment was made to reclassify a legal settlement with a customer from selling, general and administrative expense to contra-revenue in the second quarter of 2011 in the amount of for $2.6 million. Certain other immaterial adjustments were made in connection with the restatement.
The restatement adjustments did not impact the Company's previously reported tax provision or benefit in any of the affected periods, other than a $54,000 decrease in the income tax provision for the quarter ended September 30, 2012, as all of the restatement adjustments were related to our U.S. operations, for which the Company has significant net operating loss carryforwards and has not recorded an income tax expense or benefit in any period to date. However, the restatement adjustments did impact the composition of the Company's deferred tax assets and liabilities as of December 31, 2011 as presented in Note 10, Income Taxes, of the Notes to the Consolidated Financial Statements included in the Annual Report on Form 10-K for the fiscal year ended December 31, 2012.


15


The unaudited restated condensed consolidated balance sheet as of September 30, 2012 is presented below (in thousands, except per share data):
 
 
September 30, 2012
 
 
As previously reported
 
Restatement Adjustments
 
Debt Classification Adjustments
 
Restated
ASSETS
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
20,073

 
$

 
$

 
$
20,073

Trade and other accounts receivable, net of allowance for doubtful accounts of $341 at September 30, 2012
 
52,988

 
(14,172
)
 

 
38,816

Inventories
 
31,930

 
11,872

 

 
43,802

Prepaid expenses and other current assets
 
2,829

 
105

 
41

 
2,975

Total current assets
 
107,820

 
(2,195
)
 
41

 
105,666

Property and equipment, net
 
35,806

 

 

 
35,806

Intangible assets, net
 
758

 

 

 
758

Goodwill
 
24,826

 

 

 
24,826

Pension asset
 
6,945

 

 

 
6,945

Other non-current assets
 
79

 

 
(41
)
 
38

Total assets
 
$
176,234

 
$
(2,195
)
 
$

 
$
174,039

LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
Accounts payable and accrued liabilities
 
$
32,789

 
$
(800
)
 
$

 
$
31,989

Accrued warranty
 
244

 

 

 
244

Accrued employee compensation
 
5,025

 

 

 
5,025

Deferred revenue
 

 
5,149

 

 
5,149

Short-term borrowings and current portion of long-term debt
 
6,909

 

 
2,935

 
9,844

Deferred tax liability
 
499

 

 

 
499

Total current liabilities
 
45,466

 
4,349

 
2,935

 
52,750

Deferred tax liability, long-term
 
962

 

 

 
962

Long-term debt, excluding current portion
 
2,960

 

 
(2,935
)
 
25

Other long-term liabilities
 
699

 

 

 
699

Total liabilities
 
50,087

 
4,349

 

 
54,436

Commitments and contingencies (Note 11)
 
 
 
 
 
 
 
 
Stockholders’ equity:
 
 
 
 
 
 
 
 
Common stock, $0.10 par value per share, 40,000 shares authorized; 29,183 shares issued and outstanding at September 30, 2012
 
2,915

 

 

 
2,915

Additional paid-in capital
 
267,069

 

 

 
267,069

Accumulated deficit
 
(154,456
)
 
(6,544
)
 

 
(161,000
)
Accumulated other comprehensive income
 
10,619

 

 

 
10,619

Total stockholders’ equity
 
126,147

 
(6,544
)
 

 
119,603

Total liabilities and stockholders’ equity
 
$
176,234

 
$
(2,195
)
 
$

 
$
174,039


16


The restated condensed consolidated balance sheet as of December 31, 2011 is presented below (in thousands, except per share data)
 
 
December 31, 2011
 
 
As previously reported
 
Restatement Adjustments
 
Debt Classification Adjustments
 
Restated
ASSETS
 
 
 
 
 
 
 
 
Current assets:
 
 
 
 
 
 
 
 
Cash and cash equivalents
 
$
29,289

 
$

 
$

 
$
29,289

Trade and other accounts receivable, net of allowance for doubtful accounts of $450 at December 31, 2011
 
36,131

 
(8,158
)
 

 
27,973

Inventories
 
27,232

 
6,002

 

 
33,234

Prepaid expenses and other current assets
 
3,125

 
(34
)
 
61

 
3,152

Total current assets
 
95,777

 
(2,190
)
 
61

 
93,648

Property and equipment, net
 
28,541

 

 

 
28,541

Intangible assets, net
 
1,111

 

 

 
1,111

Goodwill
 
24,887

 

 

 
24,887

Pension asset
 
6,359

 

 

 
6,359

Other non-current assets
 
261

 

 
(61
)
 
200

Total assets
 
$
156,936

 
$
(2,190
)
 
$

 
$
154,746

LIABILITIES AND STOCKHOLDERS’ EQUITY
 
 
 
 
 
 
 
 
Current liabilities:
 
 
 
 
 
 
 
 
Accounts payable and accrued liabilities
 
$
36,103

 
$
(3
)
 
$

 
$
36,100

Accrued warranty
 
258

 

 

 
258

Accrued employee compensation
 
6,243

 
100

 

 
6,343

Deferred revenue
 
1,042

 

 

 
1,042

Short-term borrowings and current portion of long-term debt
 
5,431

 

 

 
5,431

Deferred tax liability
 
499

 

 

 
499

Total current liabilities
 
49,576

 
97

 

 
49,673

Deferred tax liability, long-term
 
933

 

 

 
933

Long-term debt, excluding current portion
 
68

 

 

 
68

Other long-term liabilities
 
3,028

 

 

 
3,028

Total liabilities
 
53,605

 
97

 

 
53,702

Commitments and contingencies (Note 11)
 
 
 
 
 
 
 
 
Stockholders’ equity:
 
 
 
 
 
 
 
 
Common stock, $0.10 par value per share, 40,000 shares authorized; 28,174 shares issued and outstanding at December 31, 2011
 
2,815

 

 

 
2,815

Additional paid-in capital
 
252,907

 

 

 
252,907

Accumulated deficit
 
(163,021
)
 
(2,287
)
 

 
(165,308
)
Accumulated other comprehensive income
 
10,630

 

 

 
10,630

Total stockholders’ equity
 
103,331

 
(2,287
)
 

 
101,044

Total liabilities and stockholders’ equity
 
$
156,936

 
$
(2,190
)
 
$

 
$
154,746


17


The unaudited restated condensed quarterly consolidated statements of operations for the three months ended September 30, 2012 and 2011, respectively are presented below (in thousands, except per share data):
 
 
Three months ended September 30, 2012
 
 
As Previously Reported
 
Restatement Adjustments
 
Restated
Revenue
 
$
43,907

 
$
(1,194
)
 
$
42,713

Cost of revenue
 
25,534

 
(963
)
 
24,571

Gross profit
 
18,373

 
(231
)
 
18,142

Operating expenses:
 
 
 
 
 
 
Selling, general and administrative
 
7,344

 
(2
)
 
7,342

Research and development
 
5,084

 

 
5,084

Total operating expenses
 
12,428

 
(2
)
 
12,426

Income from operations
 
5,945

 
(229
)
 
5,716

Interest expense, net
 
(56
)
 

 
(56
)
Amortization of debt discount and prepaid debt costs
 
(16
)
 

 
(16
)
Income from operations before income taxes
 
5,873

 
(229
)
 
5,644

Income tax provision
 
470

 
(54
)
 
416

Net income
 
$
5,403

 
$
(175
)
 
$
5,228

Net income per share:
 
 
 
 
 
 
Basic
 
$
0.19

 
$
(0.01
)
 
$
0.18

Diluted
 
$
0.19

 
$
(0.01
)
 
$
0.18

Weighted average common shares outstanding:
 
 
 
 
 
 
Basic
 
28,736

 
 
 
28,736

Diluted
 
28,748

 
 
 
28,748


 
 
Three months ended September 30, 2011
 
 
As Previously Reported
 
Restatement Adjustments
 
Restated
Revenue
 
$
41,096

 
$
934

 
$
42,030

Cost of revenue
 
24,547

 
653

 
25,200

Gross profit
 
16,549

 
281

 
16,830

Operating expenses:
 
 
 
 
 
 
Selling, general and administrative
 
9,595

 
10

 
9,605

Research and development
 
5,707

 

 
5,707

Total operating expenses
 
15,302

 
10

 
15,312

Income from operations
 
1,247

 
271

 
1,518

Interest expense, net
 
(27
)
 

 
(27
)
Income from operations before income taxes
 
1,220

 
271

 
1,491

Income tax provision
 
922

 

 
922

Net income
 
$
298

 
$
271

 
$
569

Net income per share:
 
 
 
 
 
 
Basic
 
$
0.01

 
$
0.01

 
$
0.02

Diluted
 
$
0.01

 
$
0.01

 
$
0.02

Weighted average common shares outstanding:
 
 
 
 
 
 
Basic
 
27,733

 
 
 
27,733

Diluted
 
28,161

 
 
 
28,161


18


The unaudited restated condensed consolidated statements of operations for the nine months ended September 30, 2012 and 2011, respectively are presented below (in thousands, except per share data):
 
 
Nine months ended September 30, 2012
 
 
As Previously Reported
 
Restatement Adjustments
 
Restated
Revenue
 
$
123,993

 
$
(9,238
)
 
$
114,755

Cost of revenue
 
72,503

 
(5,571
)
 
66,932

Gross profit
 
51,490

 
(3,667
)
 
47,823

Operating expenses:
 
 
 
 
 
 
Selling, general and administrative
 
24,868

 
671

 
25,539

Research and development
 
15,974

 
(26
)
 
15,948

Total operating expenses
 
40,842

 
645

 
41,487

Income from operations
 
10,648

 
(4,312
)
 
6,336

Interest expense, net
 
(138
)
 

 
(138
)
Amortization of debt discount and prepaid debt costs
 
(42
)
 

 
(42
)
Income from operations before income taxes
 
10,468

 
(4,312
)
 
6,156

Income tax provision
 
1,903

 
(54
)
 
1,849

Net income
 
$
8,565

 
$
(4,258
)
 
$
4,307

Net income per share:
 
 
 
 
 
 
Basic
 
$
0.30

 
$
(0.15
)
 
$
0.15

Diluted
 
$
0.30

 
$
(0.15
)
 
$
0.15

Weighted average common shares outstanding:
 
 
 
 
 
 
Basic
 
28,511

 
 
 
28,511

Diluted
 
28,695

 
 
 
28,695

 
 
Nine months ended September 30, 2011
 
 
As previously reported
 
Restatement Adjustments
 
Restated
Revenue
 
$
114,818

 
$
(5,018
)
 
$
109,800

Cost of revenue
 
68,909

 
(1,169
)
 
67,740

Gross profit
 
45,909

 
(3,849
)
 
42,060

Operating expenses:
 
 
 
 
 
 
Selling, general and administrative
 
29,378

 
(2,619
)
 
26,759

Research and development
 
16,976

 

 
16,976

Total operating expenses
 
46,354

 
(2,619
)
 
43,735

Loss from operations
 
(445
)
 
(1,230
)
 
(1,675
)
Interest expense, net
 
(88
)
 

 
(88
)
Amortization of debt discount and prepaid debt costs
 
(55
)
 

 
(55
)
Gain on embedded derivatives
 
1,086

 

 
1,086

Income (loss) from operations before income taxes
 
498

 
(1,230
)
 
(732
)
Income tax provision
 
1,221

 

 
1,221

Net loss
 
$
(723
)
 
$
(1,230
)
 
$
(1,953
)
Net loss per share:
 
 
 
 
 
 
Basic
 
$
(0.03
)
 
$
(0.04
)
 
$
(0.07
)
Diluted
 
$
(0.03
)
 
$
(0.04
)
 
$
(0.07
)
Weighted average common shares outstanding:
 
 
 
 
 
 
Basic
 
27,564

 
 
 
27,564

Diluted
 
27,564

 
 
 
27,564


19


The unaudited restated condensed consolidated statements of cash flows for the nine months ended September 30, 2012 and 2011, respectively are presented below (in thousands):
 
 
Nine Months Ended September 30, 2012
 
 
As Previously Reported
 
Revenue Restatement Adjustments
 
Restated
OPERATING ACTIVITIES:
 
 
 
 
 
 
Net income
 
$
8,565

 
$
(4,258
)
 
$
4,307

Adjustments to reconcile net income to net cash used in operating activities:
 
 
 
 
 
 
Depreciation
 
5,104

 

 
5,104

Amortization of intangible assets
 
351

 

 
351

Amortization of debt discount and prepaid debt costs
 
42

 

 
42

Pension cost
 
135

 

 
135

Stock-based compensation expense
 
2,561

 

 
2,561

Recovery of losses on accounts receivable
 
(237
)
 
127

 
(110
)
Changes in operating assets and liabilities:
 
 
 
 
 
 
Trade and other accounts receivable
 
(16,673
)
 
5,891

 
(10,782
)
Inventories
 
(4,700
)
 
(5,870
)
 
(10,570
)
Prepaid expenses and other assets
 
478

 
(139
)
 
339

Accounts payable and accrued liabilities and deferred revenue
 
(3,626
)
 
3,655

 
29

Accrued employee compensation
 
(1,296
)
 
2,019

 
723

Deferred tax liability, long term
 
29

 
(1,425
)
 
(1,396
)
Other long-term liabilities
 
(2,326
)
 

 
(2,326
)
Net cash used in operating activities
 
(11,593
)
 

 
(11,593
)
INVESTING ACTIVITIES:
 
 
 
 
 
 
Purchases of property and equipment
 
(13,121
)
 

 
(13,121
)
Net cash used in investing activities
 
(13,121
)
 

 
(13,121
)
FINANCING ACTIVITIES:
 
 
 
 
 
 
Principal payments on long-term debt and short-term borrowings
 
(6,890
)
 

 
(6,890
)
Proceeds from long-term and short-term borrowings
 
11,230

 

 
11,230

Proceeds from sale of common stock, net of offering costs
 
10,283

 

 
10,283

Repurchase of shares
 
(319
)
 

 
(319
)
Proceeds from issuance of common stock under equity compensation plans
 
1,737

 

 
1,737

Net cash provided by financing activities
 
16,041

 

 
16,041

Decrease in cash and cash equivalents from operations
 
(8,673
)
 

 
(8,673
)
Effect of exchange rate changes on cash and cash equivalents
 
(543
)
 

 
(543
)
Decrease in cash and cash equivalents
 
(9,216
)
 

 
(9,216
)
Cash and cash equivalents, beginning of period
 
29,289

 

 
29,289

Cash and cash equivalents, end of period
 
$
20,073

 
$

 
$
20,073



20


 
 
Nine Months Ended September 30, 2011
 
 
As Previously Reported
 
Restatement Adjustments
 
Restated
OPERATING ACTIVITIES:
 
 
 
 
 
 
Net loss
 
$
(723
)
 
$
(1,230
)
 
$
(1,953
)
Adjustments to reconcile net loss to net cash used in operating activities:
 
 
 
 
 
 
Depreciation
 
4,335

 

 
4,335

Amortization of intangible assets
 
422

 

 
422

Amortization of debt discount and prepaid debt costs
 
55

 

 
55

Gain on embedded derivatives
 
(1,086
)
 

 
(1,086
)
Pension cost
 
186

 

 
186

Stock-based compensation expense
 
2,440

 

 
2,440

Provision for losses on accounts receivable
 
304

 
(5
)
 
299

Changes in operating assets and liabilities:
 
 
 
 
 
 
Trade and other accounts receivable
 
(4,430
)
 
1,836

 
(2,594
)
Inventories
 
(8,621
)
 
(1,696
)
 
(10,317
)
Prepaid expenses and other assets
 
722

 
(13
)
 
709

Accounts payable and accrued liabilities and deferred revenue
 
4,204

 
1,108

 
5,312

Accrued employee compensation
 
954

 

 
954

Other long-term liabilities
 
(5,583
)
 

 
(5,583
)
Net cash used in operating activities
 
(6,821
)
 

 
(6,821
)
INVESTING ACTIVITIES:
 
 
 
 
 
 
Purchases of property and equipment
 
(10,994
)
 

 
(10,994
)
Net cash used in investing activities
 
(10,994
)
 

 
(10,994
)
FINANCING ACTIVITIES:
 
 
 
 
 
 
Principal payments on long-term debt and short-term borrowings
 
(10,254
)
 

 
(10,254
)
Proceeds from long-term and short-term borrowings
 
10,047

 

 
10,047

Repurchase of shares
 
(154
)
 

 
(154
)
Proceeds from issuance of common stock under equity compensation plans
 
2,561

 

 
2,561

Release of restricted cash
 
8,000

 

 
8,000

Net cash provided by financing activities
 
10,200

 

 
10,200

Decrease in cash and cash equivalents from operations
 
(7,615
)
 

 
(7,615
)
Effect of exchange rate changes on cash and cash equivalents
 
(1,226
)
 

 
(1,226
)
Decrease in cash and cash equivalents
 
(8,841
)
 

 
(8,841
)
Cash and cash equivalents, beginning of period
 
39,829

 

 
39,829

Cash and cash equivalents, end of period
 
$
30,988

 
$

 
$
30,988



21


Note 3 – Balance Sheet Details (in thousands)
Inventories 
 
 
September 30, 2012
 
December 31, 2011
 
 
(Restated)
 
(Restated)
Raw material and purchased parts
 
$
13,553

 
$
9,661

Work-in-process
 
2,508

 
3,942

Finished goods
 
16,331

 
14,133

Consigned finished goods
 
11,410

 
5,498

Total inventories
 
$
43,802

 
$
33,234

Intangible Assets
Intangible assets consisted of the following:
 
 
Gross
Carrying
Value
 
Accumulated
Amortization
 
Foreign
Currency
Adjustment
 
Net
Carrying
Value
As of September 30, 2012
 
 
 
 
 
 
 
 
Patents
 
$
2,476

 
$
(1,852
)
 
$

 
$
624

Developed core technology
 
1,100

 
(1,100
)
 

 

Patent license agreement
 
741

 
(571
)
 
(36
)
 
134

Total intangible assets at September 30, 2012
 
$
4,317

 
$
(3,523
)
 
$
(36
)
 
$
758

 
 
Gross
Carrying
Value
 
Accumulated
Amortization
 
Foreign
Currency
Adjustment
 
Net
Carrying
Value
As of December 31, 2011
 
 
 
 
 
 
 
 
Patents
 
$
2,476

 
$
(1,699
)
 
$

 
$
777

Developed core technology
 
1,100

 
(1,050
)
 
29

 
79

Patent license agreement
 
741

 
(468
)
 
(18
)
 
255

Total intangible assets at December 31, 2011
 
$
4,317

 
$
(3,217
)
 
$
11

 
$
1,111

Goodwill
The change in the carrying amount of goodwill from December 31, 2011 to September 30, 2012 is as follows:
Balance at December 31, 2011
 
$
24,887

Foreign currency translation adjustments
 
(61
)
Balance at September 30, 2012
 
$
24,826

Accrued Warranty
 
 
Nine Months Ended
 
 
September 30,
 
 
2012
 
2011
Beginning balance
 
$
258

 
$
449

Product warranties issued
 
278

 
242

Settlement of warranties
 
(154
)
 
(160
)
Change related to preexisting warranties
 
(138
)
 
(283
)
Foreign currency translation adjustments
 

 
13

Ending balance
 
$
244

 
$
261


22


Accumulated Other Comprehensive Income
 
 
Foreign
Currency
Translation
Adjustment
 
Defined Benefit
Pension Plan
 
Accumulated
Other
Comprehensive
Income
Balance as of December 31, 2011
 
$
14,580

 
$
(3,950
)
 
$
10,630

Current period change
 
(176
)
 
165

 
(11
)
Balance as of September 30, 2012
 
$
14,404

 
$
(3,785
)
 
$
10,619

Note 4 – Convertible Debentures
On December 20, 2005, the Company issued $25 million in aggregate principal amount of senior subordinated convertible debentures (the “Debentures”) due and payable in quarterly installments of $2.8 million which commenced December 2008. However, the holder, at its election, could defer each quarterly payment one time, for a 24 month period. As the holder had elected to defer some quarterly installments, the outstanding principal of the Debentures at December 31, 2010 was $8.3 million. In February 2011, the holder of the Debentures converted the remaining $8.3 million principal balance into 514,086 shares of the Company’s common stock at a conversion price of $16.21 per share. On the conversion date, the common stock had a fair value of $9.3 million, which was based on the closing market price. This conversion resulted in a gain of $1.0 million, which is included in “gain on embedded derivatives” in the consolidated statement of operations for the nine months ended September 30, 2011. As long as the Debentures were outstanding, the Company was required to maintain a minimum cash balance of $8.0 million. The cash restriction was released in February 2011 when the outstanding principal amount of the convertible debentures was converted to shares of the Company’s common stock.
Interest paid with cash and principal converted into shares of common stock are as follows (in thousands):
 
 
Nine months ended September 30, 2011
 
 
Value
 
Shares
Conversion of principal into shares of common stock
 
$
8,333

 
$
514

Interest paid with cash
 
17

 

Total debenture payments
 
$
8,350

 
$
514

Until the conversion of the remaining principal balance in February 2011, the principal balance was convertible by the holder at any time into common shares. In addition, after eighteen months from the issue date, the Company could have required that a specified amount of the principal of the Debentures be converted if certain conditions were satisfied for a period of 20 consecutive trading days. The Company accounted for the conversion options in the Debentures as derivative liabilities in accordance with the Derivatives and Hedging Topic of the FASB ASC. The discount at the issuance date of $9.2 million related to the fair value of the conversion options and embedded warrants issued in connection with the Debentures, and debt issuance costs, were amortized using the effective interest method over the term of the Debentures. For the nine months ended September 30, 2011, $6,000 of the discount and prepaid fees were amortized. Upon conversion of the remaining principal balance of the Debentures into shares of the Company’s common stock in February 2011, the remaining unamortized discount was written off and is included in “amortization of debt discount and prepaid debt costs” in the consolidated statement of operations.
For the nine months ended September 30, 2011, the change in fair value on revaluation of the conversion rights was the difference between the fair value on the conversion date in February 2011 and the fair value at the beginning of the period using the value calculated by the Black-Scholes pricing model. The effect of the fair market value adjustment for nine months ended September 30, 2011 was a $78,000 gain, which is recorded as “gain on embedded derivatives” in the consolidated statement of operations.
As long as the Debentures were outstanding, the Company was required to maintain a minimum cash balance of $8.0 million. The cash restriction was released in February 2011 when the outstanding principal amount of the convertible debentures was converted to shares of the Company’s common stock.
Note 5 – Credit Facility
In December 2011, the Company obtained a secured credit facility in the form of a revolving line of credit up to a maximum of $15.0 million (the “Revolving Line of Credit”) and an equipment term loan (the “Equipment Term Loan”) (together, the “Credit Facility”). In general, amounts borrowed under the Credit Facility are secured by a lien on all of the Company’s assets other than its intellectual property. In addition, under the credit agreement, the Company is required to pledge 65.0% of its equity interests in its Swiss subsidiary. The Company has also agreed not to encumber any of its intellectual

23


property. The agreement contains certain restrictive covenants that limit the Company’s ability to, amongst other things; (i) incur additional indebtedness or guarantees; (ii) create liens or other encumbrances on its property; (iii) enter into a merger or similar transaction; (iv) invest in another entity; (v) declare or pay dividends; and (vi) invest in fixed assets in excess of a defined dollar amount. Repayment of amounts owed pursuant to the Credit Facility may be accelerated in the event that the Company is in violation of the representations, warranties and covenants made in the credit agreement, including certain financial covenants. The financial covenants that the Company must meet during the term of the credit agreement include quarterly minimum liquidity ratios, minimum quick ratios and EBITDA targets and an annual net income target. Borrowings under the Credit Facility bear interest, payable monthly, at either (i) the bank's prime rate or (ii) LIBOR plus 2.25%, at the Company's option subject to certain limitations. Further, the Company incurs an unused commitment fee, payable quarterly, equal to 0.25% per annum of the average daily unused amount of the Revolving Line of Credit.
As a result of the restatement of prior period financial statements, as such financial information was previously submitted to the bank has since proven to be materially incorrect, the Company was in default with respect to the terms of the credit agreement beginning in the fourth quarter of 2011. In addition, as a result of the restatement of prior period financial statements, the Company was not in compliance with the financial covenant pertaining to the annual minimum net income target for the fiscal year ended December 31, 2011. Although, the Company did meet the financial covenants of the credit agreement in all other periods since the Credit Facility was entered into, including as of December 31, 2012, these violations represent events of default under the terms of the Credit Facility. As a result of this noncompliance, the bank's obligation to extend any further credit has ceased and terminated.
In June 2013, the Company entered into a forbearance agreement with the bank (“the Forbearance Agreement”). Pursuant to the terms of the Forbearance Agreement, the bank agreed to forbear from further exercise of its rights and remedies under the credit agreement to call the Company's outstanding debt obligation in connection with the events of default for a period terminating on the earlier of September 30, 2013 or the occurrence of any additional events of default. In connection with the execution of the Forbearance Agreement, in June 2013, the Company posted a cash deposit of $1.8 million with the bank and granted the bank a security interest therein, which will remain restricted until the bank may determine to waive the existing events of defaults discussed above, or the loan is satisfied.
As borrowings outstanding under the Credit Facility were immediately callable by the bank for each of the quarterly and annual periods since and including the fourth quarter of 2011, borrowings outstanding under the Credit Facility have been classified as a current obligation in the each of the accompanying condensed consolidated balance sheets.
As of September 30, 2012, $4.5 million was outstanding under the Equipment Term Loan and the applicable interest rate was LIBOR plus 2.25% (2.5% as of September 30, 2012). If the bank does not exercise its right to accelerate repayment, under the original terms of the Credit Facility, principal and interest under the Equipment Term Loan are payable in 36 equal monthly installments such that the Equipment Term Loan is fully repaid by the maturity date of April 30, 2015, but may be prepaid in whole or in part at any time. As of September 30, 2012, no amounts were outstanding under the Revolving Line of Credit. Since September 30, 2012, the Company has not made any additional borrowings on the Equipment Term Loan or the Revolving Line of Credit, and as a result of the events of default discussed above, the Company is currently not eligible to borrow any additional amounts under the Credit Facility.
Note 6 – Fair Value Measurements
The Company records certain financial instruments at fair value in accordance with the Fair Value Measurements and Disclosures Topic of the FASB ASC. As of September 30, 2012, the financial instruments to which this topic applied were foreign currency forward contracts. As of September 30, 2012, the fair value of these foreign currency forward contracts was an asset of $348,000 which is recorded in “trade and other accounts receivable, net” in the consolidated balance sheet. The fair value of these derivative instruments is measured using models following quoted market prices in active markets for identical instruments, which is a Level 2 input under the fair value hierarchy of the Fair Value Measurements and Disclosures Topic of the FASB ASC.
The carrying value of short-term and long-term borrowings approximates fair value because of the relative short maturity of these instruments and the interest rates the Company could currently obtain.

24


Note 7 – Foreign Currency Derivative Instruments
Maxwell uses forward contracts to hedge certain monetary assets and liabilities, primarily receivables and payables, denominated in a foreign currency. The change in fair value of these instruments represents a natural hedge as gains and losses offset the changes in the underlying fair value of the monetary assets and liabilities due to movements in currency exchange rates. These contracts generally expire in one month. These contracts are considered economic hedges and are not designated as hedges under the Derivatives and Hedging Topic of the FASB ASC, therefore, the change in the fair value of the instrument is recognized currently in the consolidated statement of operations.
The net gains and losses on foreign currency forward contracts included in cost of revenue and selling, general and administrative expense are as follows (in thousands):
 
 
Three Months Ended
 
Nine Months Ended
 
 
September 30,
 
September 30,
 
 
2012
 
2011
 
2012
 
2011
Cost of revenue
 
$
1

 
$
(45
)
 
$
1

 
$
(282
)
Selling, general and administrative
 
174

 
(1,273
)
 
(308
)
 
742

Total gain (loss)
 
$
175

 
$
(1,318
)
 
$
(307
)
 
$
460

The net gains and losses on foreign currency forward contracts were partially offset by net gains and losses on the underlying monetary assets and liabilities. Foreign currency gains and losses on those underlying monetary assets and liabilities included in cost of revenue and selling, general and administrative expense are as follows (in thousands):
 
 
Three Months Ended
 
Nine Months Ended
 
 
September 30,
 
September 30,
 
 
2012
 
2011
 
2012
 
2011
Cost of revenue
 
$
(1
)
 
$
(74
)
 
$
13

 
$
149

Selling, general and administrative
 
(357
)
 
1,271

 
(100
)
 
(918
)
Total gain (loss)
 
$
(358
)
 
$
1,197

 
$
(87
)
 
$
(769
)
As of September 30, 2012, the total notional amount of foreign currency forward contracts not designated as hedges was $23.0 million. The fair value of these derivatives was a $348,000 asset as of September 30, 2012. For additional information, refer to Note 6 - Fair Value Measurements.
Note 8 – Stock Plans
The Company has two active stock-based compensation plans as of September 30, 2012: the 2004 Employee Stock Purchase Plan and the 2005 Omnibus Equity Incentive Plan under which incentive stock options, non-qualified stock options, restricted stock awards and restricted stock units can be granted to employees and non-employee directors.
Stock Options
Compensation expense recognized from employee stock options for the three months ended September 30, 2012 and 2011 was $156,000 and $322,000, respectively, and $867,000 and $1.1 million for the nine months ended September 30, 2012 and 2011, respectively. Beginning in 2011, the Company ceased granting stock options and began granting restricted stock awards to employees as part of its annual equity incentive award program. The Company may determine to grant stock options in the future under the Incentive Plan.

25


Restricted Stock Awards
The Company did not grant any restricted stock awards during the three months ended September 30, 2012. During the three months ended September 30, 2011, the Company issued 1,200 shares, upon granting of restricted stock awards, which had an average grant date fair value per share of $15.60. During the nine months ended September 30, 2012 and 2011, the Company issued 251,066 and 217,116 shares, respectively, upon granting of restricted stock awards, which had an average grant date fair value per share of $20.81 and $18.92, respectively. The following table summarizes the amount of compensation expense recognized for restricted stock awards for the three and nine months ended September 30, 2012 and 2011 (in thousands): 
 
 
Three Months Ended
 
Nine Months Ended
 
 
September 30,
 
September 30,
 
 
2012
 
2011
 
2012
 
2011
Service-based restricted stock
 
$
369

 
$
170

 
$
1,216

 
$
635

Performance-based restricted stock
 
(198
)
 
91

 
(37
)
 
241

Total compensation expense recognized for restricted stock awards
 
$
171

 
$
261

 
$
1,179

 
$
876

Restricted Stock Units
Beginning in 2011, non-employee directors receive an annual restricted stock unit award as part of their annual retainer compensation, which vests one year from the date of grant. During the three months ended September 30, 2012 and 2011, no restricted stock units were granted. During the nine months ended September 30, 2012 and 2011, non-employee directors were granted a total of 20,342 and 22,036 restricted stock units, respectively, with an average grant date fair value per share of $20.65 and $19.06, respectively.
Total compensation expense recognized for service-based restricted stock unit awards was $106,000 and $106,000 during the three months ended September 30, 2012 and 2011, respectively, and $316,000 and $268,000 for the nine months ended September 30, 2012 and 2011, respectively.
Employee Stock Purchase Plan
The Employee Stock Purchase Plan (“ESPP”) permits substantially all employees to purchase common stock through payroll deductions, at 85% of the lower of the trading price of the stock at the beginning or at the end of each six month offering period commencing on January 1 and July 1. The number of shares purchased is based on participants’ contributions made during the offering period. In 2013, the Company suspended its ESPP Plan because the registration statement on Form S-8 became ineffective as a result of the restatement of the Company's previously issued financial statements (as discussed in Note 2, Restatement of Previously Issued Financial Statements).
Compensation expense recognized for the ESPP for the three months ended September 30, 2012 and 2011 was $72,000 and $46,000, respectively, and $199,000 and $159,000 for the nine months ended September 30, 2012 and 2011, respectively. The fair value of the ESPP shares was estimated using the Black-Scholes valuation model for a call and a put option with the following weighted-average assumptions:
 
 
Three Months Ended
 
Nine Months Ended
 
 
September 30,
 
September 30,
 
 
2012
 
2011
 
2012
 
2011
Expected dividends
 
$

 
$

 
$

 
$

Exercise price
 
$
5.58

 
$
16.19

 
$
8.93

 
$
18.01

Expected volatility
 
83
%
 
33
%
 
75
%
 
43
%
Average risk-free interest rate
 
0.16
%
 
0.10
%
 
0.12
%
 
0.16
%
Expected life/term (in years)
 
0.5

 
0.5

 
0.5

 
0.5

Fair value per share
 
$
2.78

 
$
3.94

 
$
3.79

 
$
5.00

Stock-based Compensation Expense
Compensation cost for restricted stock, restricted stock units, employee stock options and the ESPP included in cost of revenue; selling, general and administrative expense; and research and development expense is as follows (in thousands):

26


 
 
Three Months Ended
 
Nine Months Ended
 
 
September 30,
 
September 30,
 
 
2012
 
2011
 
2012
 
2011
Cost of revenue
 
$
163

 
$
89

 
$
543

 
$
292

Selling, general and administrative
 
213

 
531

 
1,586

 
1,773

Research and development
 
129

 
115

 
432

 
375

Total stock-based compensation expense
 
$
505

 
$
735

 
$
2,561

 
$
2,440

Note 9 – Stock Offering
In April 2011, the Company filed a shelf registration statement on Form S-3 with the SEC to, from time to time, sell up to an aggregate of $125 million of its common stock, warrants or debt securities. On August 19, 2011, the registration statement was declared effective by the SEC. In February 2012, the Company entered into an At-the-Market Equity Offering Sales Agreement (“Sales Agreement”) with Citadel Securities LLC (“Citadel”) pursuant to which the Company could sell, at its option, up to an aggregate of $30.0 million in shares of common stock through Citadel, as sales agent. The Company will pay Citadel a commission equal to 2% of the gross proceeds from the sale of shares of the Company’s common stock under the Sales Agreement. During the three months ended March 31, 2012, 572,510 shares of the Company's common stock were sold under this agreement for net proceeds to the Company of $10.3 million. No shares were sold subsequent to the quarter ended March 31, 2012.
Beginning in March 2013, as a result of the restatement of the Company's previously issued financial statements (as discussed in Note 2, Restatement of Previously Issued Financial Statements), the Company is no longer in compliance with the ongoing eligibility requirements of this shelf registration statement on Form S-3, and the shelf registration statement is therefore no longer effective.
Note 10 – Defined Benefit Plan
Maxwell SA, a subsidiary of the Company, has a retirement plan that is classified as a defined benefit pension plan. The employee pension benefit is based on compensation, length of service and credited investment earnings. The plan guarantees both a minimum rate of return as well as minimum annuity purchase rates. The Company’s funding policy with respect to the pension plan is to contribute the amount required by Swiss law, using the required percentage applied to the employee’s compensation. In addition, participating employees are required to contribute to the pension plan. This plan has a measurement date of December 31.
Components of net periodic pension cost are as follows (in thousands):
 
 
Three Months Ended
 
Nine Months Ended
 
 
September 30,
 
September 30,
 
 
2012
 
2011
 
2012
 
2011
Service cost
 
$
164

 
$
213

 
$
502

 
$
601

Interest cost
 
159

 
193

 
487

 
543

Expected return on plan assets
 
(342
)
 
(435
)
 
(1,048
)
 
(1,227
)
Prior service cost amortization
 
11

 
12

 
32

 
35

Deferred loss amortization
 
53

 
83

 
162

 
234

Net periodic pension cost
 
$
45

 
$
66

 
$
135

 
$
186

Employer contributions of $173,000 and $207,000 were paid during the three months ended September 30, 2012 and 2011, respectively. Employer contributions of $544,000 and $592,000 were paid during the nine months ended September 30, 2012 and 2011, respectively. Additional employer contributions of approximately $137,000 are expected to be paid during the remainder of fiscal 2012.
Note 11 – Legal Proceedings
Although the Company expects to incur significant legal costs in connection with the below legal proceedings, the Company is unable to estimate the amount of such legal costs and therefore, such costs will be expensed in the period the legal services are performed.
FCPA Matter

27


As a result of being a publicly traded company in the U.S., the Company is subject to the U.S. Foreign Corrupt Practices Act (“FCPA”), which prohibits companies from making improper payments to foreign officials for the purpose of obtaining or retaining business. Beginning in 2009, the Company conducted an internal review into payments made to its former independent sales agent in China with respect to sales of the Company's high voltage capacitor products produced by its Swiss subsidiary. In January 2011, the Company reached settlements with the SEC and the U.S. Department of Justice (“DOJ”) with respect to charges asserted by the SEC and DOJ relating to the anti-bribery, books and records, internal controls, and disclosure provisions of the FCPA and other securities laws violations. The Company settled civil charges with the SEC, agreeing to an injunction against further violations of the FCPA. Under the terms of the settlement with the SEC, the Company agreed to pay a total of approximately $6.4 million in profit disgorgement and prejudgment interest, in two installments, with $3.2 million paid in each of the first quarters of 2011 and 2012. Under the terms of the settlement with the DOJ, the Company agreed to pay a total of $8.0 million in penalties in three installments, with $3.5 million paid in the first quarter of 2011, $2.3 million paid in the first quarter of 2012 and $2.3 million payable in the first quarter of 2013. As part of the settlement, the Company entered into a three-year deferred prosecution agreement (“DPA”) with the DOJ. If the Company remain in compliance with the terms of the DPA, at the conclusion of the term, the charges against the Company asserted by the DOJ will be dismissed with prejudice. Further, under the terms of the agreements, the Company will periodically report to the SEC and DOJ on its internal compliance program concerning anti-bribery. As of September 30, 2012, the Company has accrued a liability of $2.3 million for this matter, which is included in “accounts payable and accrued liabilities” on the accompanying consolidated balance sheet.
Customer Bankruptcy Matter
In January 2011, the Company attended a bankruptcy proceeding for a previous customer in order to bid on certain intellectual property and physical assets that were being auctioned. During this proceeding, an offer for sale was presented for any and all potential claims held by the previous customer against the Company. These potential claims related primarily to payments made to the Company prior to the previous customer filing bankruptcy, as well as a potential intellectual property dispute between the Company and the previous customer. At the January 2011 bankruptcy proceeding, the Company bid $250,000 to purchase the right to any and all claims against the Company stemming from rights held by the previous customer. However, following the auction, the previous customer essentially declined this offer for settlement. Since this time, in the interest of a more expedient resolution to this matter, the Company recently increased its settlement offer to $750,000. However, this settlement offer was rejected by the previous customer. The Company believes that it has strong legal defenses against any and all potential claims related to this matter, and does not believe a settlement amount in excess of $750,000 is likely. The Company’s current estimate of the range of loss on this matter is $750,000 to $1,100,000, with the low end of this range based on the Company’s recent settlement offer, and the high end of the range based on the amount the Company expects that the previous customer would immediately accept without further negotiation. The Company has accrued a total of $750,000 as the estimated loss on this matter, which is included in “accounts payable and accrued liabilities” in the consolidated balance sheet as of September 30, 2012.
The following legal matters developed subsequent to the quarter ended September 30, 2012.
Securities Matter
In early 2013, we voluntarily provided information to the United States Attorney's Office for the Southern District of California and the U.S. Securities and Exchange Commission related to our announcement that we intend to file restated financial statements for fiscal years 2011 and 2012. We are cooperating with these investigations. At this preliminary stage, we cannot predict the ultimate outcome of this action, nor can we estimate the range of potential loss, and we therefore have not accrued an amount for any potential costs associated with this action, but an adverse result could have a material adverse impact on our financial condition and results of operation.
Securities Class Action Matter
From March 13, 2013 through April 19, 2013, four purported shareholder class actions were filed in the United States District Court for the Southern District of California against us and three of our current and former officers. These actions are entitled Foster v. Maxwell Technologies, Inc., et al., Case No. 13-cv-0580 (S.D. Cal. filed March 13, 2013), Weinstein v. Maxwell Technologies, Inc., et al., No. 13-cv-0686 (S.D. Cal. filed March 21, 2013), Abanades v. Maxwell Technologies, Inc., et al., No. 13-cv-0867 (S.D. Cal. filed April 11, 2013), and Mebarak v. Maxwell Technologies, Inc., et al., No. 13-cv-0942 (S.D. Cal. filed April 19, 2013). The complaints allege that the defendants made false and misleading statements regarding our financial performance and business prospects and overstated our reported revenue. The complaints purport to assert claims for violations of Section 10(b) and 20(a) of the Securities Exchange Act of 1934 and SEC Rule 10b-5 on behalf of all persons who purchased our common stock between April 28, 2011 and March 7, 2013, inclusive. The complaints seek unspecified monetary damages and attorneys' fees and costs. On May 13, 2013, four prospective lead plaintiffs filed motions to consolidate the four actions and to be appointed lead plaintiff. On June 11, 2013, the Court vacated the hearing on those motions and indicated that it would issue a written order in the near future. At this preliminary stage, we cannot determine whether there is a reasonable

28


possibility that a loss has been incurred nor can we estimate the range of potential loss. Accordingly, we have not accrued an amount for any potential loss associated with this action, but an adverse result could have a material adverse impact on our financial condition and results of operation.
State Shareholder Derivative Matter
On April 11, 2013 and April 18, 2013, two shareholder derivative actions were filed in California Superior Court for the County of San Diego, entitled Warsh v. Schramm, et al., Case No. 37-2013-00043884 (San Diego Sup. Ct. filed April 11, 2013) and Neville v. Cortes, et al., Case No. 37-2013-00044911-CU-BT-CTL (San Diego Sup. Ct. filed April 18, 2013). The complaints name as defendants certain of our current and former officers and directors as well as our former auditor McGladrey LLP. We are named as a nominal defendant. The complaints allege that the individual defendants made or caused us to make false and/or misleading statements regarding our financial condition, and failed to disclose material adverse facts about our business, operations and prospects. The complaints assert causes of action for breaches of fiduciary duty for disseminating false and misleading information, failing to maintain internal controls, and failing to properly oversee and manage the company, as well as for unjust enrichment, abuse of control, gross mismanagement, professional negligence and accounting malpractice, and aiding and abetting breaches of fiduciary duty. The lawsuits seek unspecified damages, an order directing us to take all necessary actions to reform and improve its corporate governance and internal procedures, restitution and disgorgement of profits, benefits and other compensation, attorneys' and experts' fees, and costs and expenses. On May 7, 2013, the Court consolidated the two actions. We filed a motion to stay the consolidated action on July 2, 2013. Because this action is derivative in nature, it does not seek monetary damages from us. However, we may be required throughout the term of the action to advance the legal fees and costs incurred by the individual defendants and to incur other financial obligations. At this preliminary stage, we cannot predict the ultimate outcome of this action, nor can we estimate the range of potential loss, and we therefore have not accrued an amount for any potential costs associated with this action, but an adverse result could have a material adverse impact on our financial condition and results of operation.
Federal Shareholder Derivative Matter
On April 23, 2013 and May 7, 2013, two shareholder derivative actions were filed in the United States District Court for the Southern District of California, entitled Kienzle v. Schramm, et al., Case No. 13-cv-0966 (S.D. Cal. filed April 23, 2013) and Agrawal v. Cortes, et al., Case No. 13-cv-1084 (S.D. Cal. filed May 7, 2013). The complaints name as defendants certain of our current and former officers and directors and name us as a nominal defendant. The complaints allege that the individual defendants caused or allowed us to issue false and misleading statements about our financial condition, operations, management, and internal controls and falsely represented that we maintained adequate controls. The complaints assert causes of action for breach of fiduciary duty, abuse of control, gross mismanagement, waste of corporate assets and unjust enrichment. The lawsuits seek unspecified damages, an order directing us to take all necessary actions to reform and improve its corporate governance and internal procedures, restitution and disgorgement of profits, benefits, and other compensation, attorneys' and experts' fees, and costs and expenses. On June 10, 2013, the parties filed a joint motion to consolidate the two actions. The Court has not yet ruled on that motion. Because this action is derivative in nature, it does not seek monetary damages from us. However, we may be required throughout the term of the action to advance the legal fees and costs incurred by the individual defendants and to incur other financial obligations. At this preliminary stage, we cannot predict the ultimate outcome of this action, nor can we estimate the range of potential loss, and we therefore have not accrued an amount for any potential costs associated with this action, but an adverse result could have a material adverse impact on our financial condition and results of operation.
Shareholder Demand Letter Matter
On April 9, 2013, Stephen Neville, a purported shareholder of the Company, sent a demand letter to us to inspect our books and records pursuant to California Corporations Code Section 1601. The demand sought inspection of documents related to our March 7, 2013 announcement that we would be restating our previously-issued financial statements for 2011 and 2012, board minutes and committee materials, and other documents related to our board or management discussions regarding revenue recognition from January 1, 2011 to the present. We responded by letter dated April 19, 2013, explaining why we believed that the demand did not appear to be proper. Following receipt of a second letter from Mr. Neville dated April 23, 2013, we explained by letter dated April 29, 2013 why we continue to believe that the inspection demand appears improper. We have not received a further response from Mr. Neville regarding the inspection demand. At this preliminary stage, we cannot predict the ultimate outcome of this action, nor can we estimate the range of potential loss, and we therefore have not accrued an amount for any potential costs associated with this action, but an adverse result could have a material adverse impact on our financial condition and results of operation.

29


Item 2.
Management’s Discussion and Analysis of Financial Condition and Results of Operations
Unless the context otherwise requires, all references in this Quarterly Report on Form 10-Q (this “Quarterly Report”) to “Maxwell,” “the Company,” “we,” “us,” and “our” refer to Maxwell Technologies, Inc. and its subsidiaries; all references to “Maxwell SA” refer to our Swiss subsidiary, Maxwell Technologies, SA.
FORWARD-LOOKING STATEMENTS
Some of the statements contained in this document and incorporated herein by reference discuss our plans and strategies for our business or make other forward-looking statements, as this term is defined in the Private Securities Litigation Reform Act. The words “anticipates,” “believes,” “estimates,” “expects,” “plans,” “intends,” “may,” “could,” “will,” “continue,” “seek,” “should,” “would” and similar expressions are intended to identify these forward-looking statements, but are not the exclusive means of identifying them. These forward-looking statements reflect the current views and beliefs of our management; however, various risks, uncertainties and contingencies could cause our actual results, performance or achievements to differ materially from those expressed in, or implied by, our statements. Such risks, uncertainties and contingencies include, but are not limited to, the following:
our ability to remain competitive and stimulate customer demand through successful introduction of new products, and to educate our prospective customers on the products we offer;
dependence upon the sale of products to a small number of customers and vertical markets, some of which are heavily dependent on government funding or government subsidies which may or may not continue in the future;
dependence upon the sale of products into China and Europe, where macroeconomic factors outside our control may adversely affect our sales;
risks related to our international operations including, but not limited to, our ability to adequately comply with the changing rules and regulations in countries where our business is conducted, our ability to oversee and control our foreign subsidiaries and their operations, our ability to effectively manage foreign currency exchange rate fluctuations arising from our international operations, and our ability to continue to comply with the U.S. Foreign Corrupt Practices Act as well as the anti-bribery laws of foreign jurisdictions and the terms and conditions of our settlement agreements with the Securities and Exchange Commission and the Department of Justice;
successful acquisition, development and retention of key personnel;
our ability to effectively manage our reliance upon certain suppliers of key component parts and specialty equipment and logistical services;
our ability to match production volume to actual customer demand;
our ability to manage product quality problems;
our ability to protect our intellectual property rights and to defend claims against us;
our ability to effectively identify, enter into, manage and benefit from strategic alliances;
occurrence of a catastrophic event at any of our facilities;
occurrence of a technology systems failure, network disruptions, or breach in data security;
our ability to obtain sufficient capital to meet our operating or other needs; and
our ability to manage and minimize the impact of unfavorable legal proceedings.
Many of these factors are beyond our control. Additionally, there can be no assurance that we will not incur new or additional unforeseen costs in connection with the ongoing conduct of our business. Accordingly, any forward-looking statements included herein do not purport to be predictions of future events or circumstances and may not be realized.
For a discussion of important risks associated with an investment in our securities, including factors that could cause actual results to differ materially from expectations referred to in the forward-looking statements, see Risk Factors in Part II, Item 1A, of this document and Part I, Item 1A, of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2012 filed on August 1, 2013. We do not have any obligation to update publicly any forward-looking statements, whether as a result of new information, future events or otherwise.

30


Background on the Restatement
Audit Committee's Investigation
In January 2013, following receipt of information concerning potential revenue recognition issues, the Audit Committee of the Board of Directors engaged independent legal counsel and forensic accountants to conduct an investigation concerning the potential issues and to work with management to determine the potential impact on accounting for revenue. In February 2013, as a result of the findings of the Audit Committee's investigation to date, we determined that certain of our employees had engaged in conduct which resulted in revenue being recorded in periods prior to the criteria for revenue recognition under U.S. generally accepted accounting principles being satisfied.
The investigation revealed arrangements with three of our distributors regarding extended payment terms, which allowed these distributors to pay us after they received payment from their customer, and with one of our distributors regarding return rights and profit margin protection, for sales to such distributors with respect to certain transactions. In addition, arrangements were revealed with one non-distributor customer to honor transfer of title at a date later than the customer's purchase orders indicated. Based on the results of its investigation, the Audit Committee determined that these arrangements had not been communicated to our finance and accounting department, or to our CEO, and therefore, had not been considered when revenue was originally recorded. Based on the terms of the agreements with these four customers as they were known to our finance and accounting department, it had been our policy to record revenue related to shipments as title passed at either shipment from our facilities or receipt at the customer's facility, assuming all other revenue recognition criteria had been achieved. In addition to the arrangements noted above, the investigation uncovered an error on an individual transaction where a customer was given extended payment terms, which allowed them to pay us after they received payment from their customer, but those terms were not considered when revenue was originally recognized. As a result of the arrangements discovered during the investigation, we do not believe that a fixed or determinable sales price existed at the time of shipment, nor was collection reasonably assured, at least with respect to certain transactions. In addition, revenue related to certain shipments to the one non-distributor customer was recorded before the actual transfer of title and the satisfaction of our obligation to deliver the products. Therefore, revenue from these sales should not have been recognized at the time of shipment.
Based on the arrangements with customers revealed in the investigation that were not considered when revenue was originally recognized, we determined the following:
Beginning in the period in which the investigation revealed arrangements regarding extended payment terms for certain sales to three distributors, we determined it appropriate to defer revenue recognition on all sales to these distributors from the period of shipment to the period in which payment is received. For these distributors, revenue recognition in the period in which payment is received was determined to be appropriate beginning in the fourth quarter of 2011.
Beginning in the period in which the investigation revealed return rights and profit margin protection for one distributor, we determined it appropriate to defer revenue recognition on all sales to this distributor until the distributor confirms with us that they are not entitled to any further returns or credits. For this distributor, the deferral of revenue on this basis was determined to be appropriate beginning in the fourth quarter of 2011. At such time as the distributor confirms with us that they are not entitled to any further returns or credits, which is currently anticipated to occur in the second half of the fiscal year 2013, previous sales for which revenue has been deferred, net of any credits or returns that may be made by the distributor, will be recognized as revenue.
For the arrangements with the non-distributor customer to honor transfer of title at a date later than the customer's purchase order indicated, we determined it appropriate to defer revenue recognition to the period in which we agreed to honor transfer of title.
For the individual transaction where a customer was given extended payment terms which were not considered when revenue was originally recognized in the first quarter of 2011, revenue recognition in the period in which payment was received, which was in the second quarter of 2011, was determined to be appropriate.
Management's Subsequent Internal Review
Once the audit committee investigation was complete, management of the Company conducted a review beginning with the first quarter of 2009 through the first quarter of 2013 to ensure that all sales arrangements had been detected and accounted for appropriately. During this review, we noted that there were a number of quarter end revenue cut-off errors wherein revenue was recorded prior to the transfer of title to the customer and the satisfaction of our obligation to deliver the products. We have corrected these errors occurring in the first quarter of 2011 through the third quarter of 2012 by moving the revenue recognition for these items to the period in which delivery actually occurred.

31


Results of the Audit Committee's Investigation and Management's Internal Review
Based on the findings of the investigation, as previously reported in our current report on Form 8-K dated March 7, 2013, the Audit Committee, in consultation with management and the Board of Directors, concluded that our previously issued financial statements contained in our annual report on Form 10-K for the year ended December 31, 2011, and the quarterly reports on Form 10-Q for the quarters ended March 31, 2011, June 30, 2011, September 30, 2011, March 31, 2012, June 30, 2012 and September 30, 2012, should no longer be relied upon. Accordingly, the consolidated financial statements for the first three quarters of the fiscal year ended December 31, 2012, for the fiscal year ended December 31, 2011, and for each of the interim periods within the fiscal year ended December 31, 2011, have been restated in our Annual Report on Form 10-K for the fiscal year ended December 31, 2012. See Note 15, in our Annual Report on Form 10-K for the fiscal year ended December 31, 2012, for the effects of the restatement adjustments on our 2012 and 2011 unaudited quarterly financial information.
As a result of the Audit Committee's investigation, certain employees were terminated and our Sr. Vice President of Sales and Marketing resigned as reported in our current report on Form 8-K dated March 7, 2013.
In connection with the errors identified during the investigation resulting in the restatement of previously reported financial statements, we identified control deficiencies in our internal control over financial reporting that constitute material weaknesses. For a discussion of our disclosure controls and procedures and the material weaknesses identified, see Part I, Item 4, Controls and Procedures, of this Quarterly Report on Form 10-Q/A.
Our previously filed annual report on Form 10-K for the fiscal year ended December 31, 2011, and our quarterly reports on Form 10-Q for the periods affected by the restatements, have not been amended, other than this amended quarterly report on Form 10-Q for the quarter ended September 30, 2012. Accordingly, investors should no longer rely upon our previously released financial statements for any quarterly or annual periods after and including March 31, 2011, and any earnings releases or other communications relating to these periods. See Note 2, Restatement of Previously Issued Financial Statements and Financial Information, and Note 15, Unaudited Quarterly Financial Information, of the Notes to the Consolidated Financial Statements, in our Annual Report on Form 10-K for the fiscal year ended December 31, 2012, for the impact of these adjustments for the full fiscal year ended December 31, 2011, and the first three quarters of the fiscal year ended December 31, 2012 and each of the quarterly periods in the fiscal year ended December 31, 2011, respectively.
Restatement Adjustments
Restatement Adjustments Related to Sales Arrangements
Several adjustments were made to our previously filed consolidated financial statements as a result of the restatement in order to reflect revenue recognition in the appropriate periods as discussed above. Accordingly, for the subject sales transactions, revenue and accounts receivable balances were reduced by an equivalent amount in the period that the sale was originally recorded as revenue, and revenue was increased in the subsequent period in which the criteria for revenue recognition were met. Further, for the subject sales transactions, cost of revenue was reduced, and inventory was increased, in the period that the sale was originally recorded as revenue, and cost of revenue was increased, and inventory was reduced, in the period the sale was ultimately recorded as revenue. However, for sales to one distributor in which revenue is being deferred until we determine that the distributor is not entitled to any further returns or credits, as discussed above, the increase to revenue, and the related reduction to inventory and increase to cost of revenue, will be recorded in a future period when this determination is made.
The adjustments also reflect the impacts of adjusting our returns reserves for certain stock rotation rights of the distributors, and adjusting our reserves for allowances for doubtful accounts, as well as commissions expense, although these changes were not material.
In addition to the adjustments to revenue, accounts receivable, inventory and cost of revenue, inventory reserve balances and cost of revenue were adjusted in relation to the adjustments to inventory discussed above, in order to reflect inventory ultimately recorded on our balance sheets at its lower of cost or market value.
Other Restatement Adjustments
Since our determination to restate previously issued financial statements constituted an event of default under the terms of our credit facility, the bank had the right to require immediate payment of the outstanding borrowings. As a result restatement adjustments were recorded to reclassify the amounts outstanding under the credit facility from long-term debt to current liabilities as of each respective balance sheet date. In addition, an insignificant amount of debt issuance costs were reclassified from a long-term asset to a short-term asset, consistent with the classification of the related debt. In June 2013, we entered into a forbearance agreement with the bank wherein the bank agreed to forbear from further exercise of its rights and remedies to

32


call our outstanding debt under the credit facility in connection with the events of default for a period terminating on the earlier of September 30, 2013 or the occurrence of any additional events of default.
Further, a restatement adjustment was made to reclassify a legal settlement with a customer from selling, general and administrative expense to contra-revenue in the second quarter of 2011 in the amount of for $2.6 million. Certain other immaterial adjustments were made in connection with the restatement, which increased our net loss by $153,000 for the year ended December 31, 2011, and decreased our net income by $170,000 for the nine-months ended September 30, 2012.
The restatement adjustments did not impact our previously reported tax provision or benefit in any of the affected periods, other than a $54,000 decrease in the income tax provision for the quarter ended September 30, 2012, as all of the restatement adjustments were related to our U.S. operations, for which we have significant net operating loss carryforwards and have not recorded an income tax expense or benefit in any period to date. However, the restatement adjustments did impact the composition of our deferred tax assets and liabilities as of December 31, 2011 as presented in Note 10, Income Taxes, of the Notes to the Consolidated Financial Statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2012.
For the impact of the restatement adjustments on our financial statements for the three and nine months ended September 30, 2012, and 2011, see Note 2, Restatement of Previously Issued Financial Statements and Financial Information.
Unless required as a result of the restatement, we have not otherwise updated or amended the information in this amended quarterly report on Form 10-Q.
Overview
Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is designed to provide a reader of our financial statements with a narrative from the perspective of our management on our financial condition, results of operations, liquidity and certain other factors that may affect our future results. Our MD&A is presented in the following sections:
Executive Overview
Highlights of the Nine Months Ended September 30, 2012
Results of Operations
Liquidity and Capital Resources
Critical Accounting Policies and Estimates
Off Balance Sheet Arrangements
Executive Overview
Maxwell is a global leader in developing, manufacturing and marketing advanced energy storage and power delivery products for transportation, industrial, information technology and other applications, and microelectronic products for space and satellite applications. Our strategy is to establish a compelling value proposition for our products by designing and manufacturing them to perform reliably with minimal maintenance over long operational lifetimes. We have three product lines: ultracapacitors with applications in multiple industries, including transportation, automotive, information technology, renewable energy and consumer and industrial electronics; high-voltage capacitors applied mainly in electrical utility infrastructure; and radiation-hardened microelectronic products for space and satellite applications.
Our primary objective is to grow revenue and profit margins by creating and satisfying demand for ultracapacitor-based energy storage and power delivery solutions. We are focusing on establishing and expanding market opportunities for ultracapacitors and being the preferred supplier for ultracapacitor products worldwide. We believe that the transportation industry represents the largest market opportunity for ultracapacitors, primarily for applications related to engine starting, electrical system augmentation, and braking energy recuperation and hybrid electric drive systems for transit buses, trucks and autos, and electric rail vehicles. Backup power applications, including instantly available power for uninterruptible power supply may also represent a significant market opportunity.
We also seek to expand market opportunities for our high-voltage capacitor and radiation-hardened microelectronic products. The market for high-voltage capacitors consists mainly of expansion, upgrading and maintenance of existing electrical utility infrastructure and new infrastructure installations in developing countries. Such installations are capital-intensive and frequently are subject to regulation, availability of government funding and general economic conditions. Although the market for microelectronics products for space and satellite applications is relatively small, the specialized nature

33


of these products and the requirement for failure-free reliability allows us to generate profit margins significantly higher than those for commodity electronic components.
In the third quarter of 2012, revenues were $42.7 million, representing an increase of 2% compared with the same period one year ago. Revenue growth in the current fiscal year has been slower when compared with the higher annual growth rates achieved in the two most recent fiscal years, and is primarily attributable to slower revenue growth for our ultracapacitor products, for which revenue increased by 10% to $28.3 million in the third quarter of 2012 compared with the third quarter of 2011. This decline in the overall growth rate for our ultracapacitor products is primarily attributable to slowing in the two primary markets in which we currently sell our products, the hybrid transit vehicle and wind energy markets. Slower growth in sales in the hybrid transit vehicle market is primarily due to changes and delays in government programs and funding for public transit vehicle procurements, mainly in Europe. In addition, we are beginning to see a near-term reduction in customer forecasts for hybrid transit vehicle applications in China, which is our primary market. For wind energy, there has been a global slowdown in new wind system deployments in the last several quarters. These conditions, in conjunction with weaker general economic conditions in Europe and elsewhere, have caused our growth rates in these primary markets to decline in recent quarters.
Revenues for our high voltage products were relatively stable in the third quarter of 2012 compared with the same period in the prior year at $10.9 million, while revenues for our microelectronics products, which tend to be volatile, were $3.5 million for the third quarter of 2012 compared with $4.6 million for the same period in 2011. Overall gross profit margin during the quarter increased to 42% compared with 40% in the third quarter of 2011, primarily due to cost efficiencies associated with greater volume as well as cost reduction efforts. Operating expenses in the third quarter of 2012 were 29% of revenue, compared with 36% of revenue in the same period one year ago.
Going forward, we will continue to focus on trying to grow our business and strengthen our market leadership and brand recognition through further penetration of existing markets, entry into new markets and development of new products. Our primary focus will be to try to grow our ultracapacitor business through continued market penetration in primary applications, including automotive, transportation, renewable energy and backup power. In order to achieve our growth objectives, we will need to overcome risks and challenges facing our business. A significant challenge we face is our ability to manage dependence on a small number of vertical markets, including some that are driven by government regulation or are highly dependent on government subsidy programs. For example, a large portion of our current ultracapacitor business is concentrated in the Chinese hybrid transit bus and wind energy markets, which are heavily dependent on government regulation and subsidy. As mentioned above, these markets are experiencing slower rates of growth in recent quarters compared with the past couple of years related to changes or delays in government policies and subsidy programs that have historically advanced our sales into these markets. Although we believe the long-term prospects for these markets remain positive, we plan to develop growth opportunities for our products in other vertical markets, including applications for back-up power, and heavy vehicle cold starting, in order to further diversify our market presence and build our long-term growth prospects.
Other significant risks and challenges we face include the ability to maintain profitability; the ability to develop our management team, product development infrastructure and manufacturing capacity to facilitate growth; competing technologies that may capture market share and interfere with our planned growth; and hiring, developing and retaining key personnel critical to the execution of our strategy. We will be attentive to these risks and will focus on growing our revenues and profits, and on developing new products and promoting the value proposition of our products over competing technologies. In addition, we are in the process of augmenting current manufacturing capacity and infrastructure, which we believe will be sufficient to accommodate planned growth.
Highlights of the Nine Months Ended September 30, 2012
During the nine months ended September 30, 2012, we continued to focus on introducing new products, increasing production capacity to meet anticipated future demand, reducing product costs, making capital investments to facilitate growth, and improving production processes. Some of these efforts are described below:
In January, we announced that Bombardier Transportation, a leading producer of rail vehicles and rail transportation equipment, systems and services, has selected Maxwell ultracapacitors as the energy storage element of the BOMBARDIER EnerGstor® braking energy recuperation system.
Also in January, we announced that we have entered into a one-year agreement with Pana-Pacific, a preferred integrator and engineering partner in the commercial vehicle market, to distribute our new ultracapacitor-based Engine Start Module in the United States, Canada and Mexico, although sales of this product to date have not been significant.

34


In February, we announced that our Swiss subsidiary is participating in a program of the Swiss government to accelerate our initiatives to improve manufacturing processes and enhance performance of our CONDIS® high-voltage capacitor products for electric utility grid infrastructure and other high-voltage applications.
In March, we announced that we are in the process of planning a new ultracapacitor electrode production facility that will double our current electrode capacity, and are also increasing internal and outsourced assembly capabilities to ensure that we can meet increasing worldwide demand for ultracapacitor products.
In May, we announced that our Swiss subsidiary has launched a new line of CONDIS® capacitors and voltage dividers based on environmentally friendly technology for medium voltage applications.
Also in May, we announced the signing of a global distribution agreement with Digi-Key Corporation, a global electronic components distributor recognized by design engineers as having the industry’s largest selection of electronic components available for immediate shipment, who will now distribute our products worldwide.
In June, R&D Magazine recognized our ultracapacitor-based Engine Start Module for medium and heavy duty trucks as one of the 100 most technologically significant products introduced into the marketplace over the past year, although sales of this product to date have not been significant.
Results of Operations
The Third Quarter of 2012 Compared with the Third Quarter of 2011
The following table presents certain unaudited statement of operations data expressed as a percentage of revenue for the periods indicated:
 
 
Quarter Ended
 
 
September 30,
 
 
2012
 
2011
 
 
(Restated)
 
(Restated)
Revenue
 
100
%
 
100
%
Cost of revenue
 
58
%
 
60
%
Gross profit
 
42
%
 
40
%
Operating expenses:
 
 
 
 
Selling, general and administrative
 
17
%
 
23
%
Research and development
 
12
%
 
13
%
Total operating expenses
 
29
%
 
36
%
Income from operations
 
13
%
 
4
%
Interest expense, net
 
%
 

Income from operations before income taxes
 
13
%
 
4
%
Income tax provision
 
1
%
 
3
%
Net income
 
12
%
 
1
%
Net income reported for the three months ended September 30, 2012 was $5.2 million, or $0.18 per diluted share, compared with $569,000, or $0.02 per diluted share, in the same quarter one year ago. While revenue for the three months ended September 30, 2012 was relatively stable with the prior year, we were able to achieve an improved gross profit rate of 42%, compared with 40% in the same quarter of the prior year, and also reduced operating expenses, which were 29% of revenue in the current quarter, down from 36% in the same quarter of the prior year.
Revenue and Gross Profit
The following table presents a comparison of revenue, cost of revenue and gross profit for the quarters ended September 30, 2012 and 2011 (in thousands, except percentages):

35


 
 
Quarter Ended
 
Quarter Ended
 
 
 
 
 
 
September 30, 2012
 
September 30, 2011
 
 
 
 
 
 
(Restated)
 
(Restated)
 
 
 
 
 
 
Amount
 
% of
Revenue
 
Amount
 
% of
Revenue
 
Increase
 
%
Change
Revenue
 
$
42,713

 
100
%
 
$
42,030

 
100
%
 
$
683

 
2
 %
Cost of revenue
 
24,571

 
58
%
 
25,200

 
60
%
 
(629
)
 
(2
)%
Gross profit
 
$
18,142

 
42
%
 
$
16,830

 
40
%
 
$
1,312

 
8
 %
Revenue. In the third quarter of 2012, revenue increased 2% to $42.7 million, compared with $42.0 million in the same quarter one year ago. The increase in revenue was primarily due to higher revenues for our ultracapacitor product line which increased by 10% compared with the same period in the prior year, influenced primarily by sales growth in the hybrid transit bus and wind energy markets, offset by lower sales for certain backup power applications. Despite this growth, for reasons discussed earlier, growth rates for sales of our ultracapacitor products in both the hybrid transit bus and wind energy markets have recently declined significantly.
Revenues for our high voltage products decreased by $681,000 for the third quarter of 2012 compared with the same period in the prior year, while revenues for our microelectronics products, which tend to be volatile, decreased by $1.1 million for the third quarter of 2012.
Beginning in the fourth quarter of the year ended December 31, 2011, for sales to three distributors, we began recognizing revenue upon collection of the sales price, rather than upon shipment, due to certain arrangements with these distributors related to payment terms on sales. In addition, for one distributor, also beginning in the fourth quarter of the year ended December 31, 2011, due to return rights and profit margin protection given to the distributor, we began deferring revenue on all sales until such time as the distributor confirms with us that they are not entitled to any further returns or credits. As a result of these arrangements and other less significant arrangements requiring the deferral of revenue, for the quarter ended September 30, 2012, we deferred revenue recognition on $4.0 million in sales, and recognized $1.5 million of previously deferred revenue as revenue.
Related to the one distributor that was given return rights and profit margin protection for which we have deferred revenue on all sales beginning in the fourth quarter of the year ended December 31, 2011, this revenue will remain deferred until such time as the distributor confirms with us that they are not entitled to any further returns or credits. At such time as this determination is made, which is currently anticipated to occur in the second half of the fiscal year 2013, previous sales for which revenue has been deferred, net of any credits or returns that may be made by the distributor, will be recognized as revenue. As of September 30, 2012, cumulative sales to this distributor for which revenue has not yet been recognized is $6.6 million.
A substantial amount of our revenue is generated through our Swiss subsidiary which has a functional currency of the Swiss Franc. As such, reported revenue can be materially impacted by the changes in exchange rates between the Swiss Franc and the U.S. Dollar, our reporting currency. Due to the strengthening of the U.S. Dollar against the Swiss Franc during the quarter ended September 30, 2012 compared with the same period one year ago, revenue was negatively impacted by $1.6 million.
Gross Profit. In the third quarter of 2012, gross profit increased $1.3 million or 8% compared with the third quarter of 2011. As a percentage of revenue, gross profit margin increased to 42% compared with 40% in the same quarter one year ago. Of the increase in gross profit in absolute dollars, $1.1 million related to an increase in the volume of sales, and $1.0 million was due to net reductions in product costs for both our ultracapacitor and high voltage product lines. Offsetting these increases was a decrease in gross profit in absolute dollars of $816,000 related to the impact of changes in foreign currency exchange rates, primarily changes between the Swiss Franc and the U.S. Dollar.
Selling, General and Administrative Expense
The following table presents selling, general and administrative expense for the third quarter of 2012 and 2011 (in thousands, except percentages):

36


 
 
 
Quarter Ended
 
Quarter Ended
 
 
 
 
 
 
September 30, 2012
 
September 30, 2011
 
 
 
 
 
 
(Restated)
 
(Restated)
 
 
 
 
 
 
Amount
 
% of
Revenue
 
Amount
 
% of
Revenue
 
Decrease
 
%
Change
Selling, general and administrative
 
$
7,342

 
17
%
 
$
9,605

 
23
%
 
$
(2,263
)
 
(24
)%
Selling, general and administrative expenses were 17% of revenue for the third quarter of 2012, down from 23% in the same quarter one year ago, while total selling, general and administrative expenses decreased by $2.3 million, or 24%. The decrease in absolute dollars was primarily driven by a $1.1 million decrease in bonus expense, which was primarily due to the reversal of previously accrued bonus compensation related to the 2012 bonus program as the related financial targets will not likely be achieved, as well as no bonus expense having been recorded for the third quarter of 2012. In addition, stock-based compensation expense decreased by $230,000 due to the reversal of expense related to performance-based restricted stock award as the performance targets are not expected to be achieved. Further, legal expenses decreased by $1.1 million in the third quarter of 2012 in comparison with the third quarter of 2011 due to the resolution of certain legal matters. Offsetting these decreases, advertising and promotion expenses increased by $330,000 primarily associated with the rollout of a new product, the Engine Start Module, as well as increased participation in trade shows and other advertising programs.
Research and Development Expense
The following table presents research and development expense for the third quarter of 2012 and 2011 (in thousands, except percentages):
 
 
 
Quarter Ended
 
Quarter Ended
 
 
 
 
 
 
September 30, 2012
 
September 30, 2011
 
 
 
 
 
 
Amount
 
% of
Revenue
 
Amount
 
% of
Revenue
 
Decrease
 
%
Change
Research and development
 
$
5,084

 
12
%
 
$
5,707

 
13
%
 
$
(623
)
 
(11
)%
Research and development expenses were 12% of revenue for the third quarter of 2012, down from 13% in the same quarter one year ago, while total research and development expenses decreased by $623,000 or 11%. The decrease in absolute dollars was primarily driven by a $369,000 decrease in bonus expense, which was primarily due to the reversal of previously accrued bonus compensation related to the 2012 bonus program as the related financial targets will not likely be achieved, as well as no bonus expense having been recorded for the third quarter of 2012. In addition, salary and contract labor costs decreased by $278,000 primarily related to higher contract labor costs incurred in 2011 for the design of the Engine Start Module.
Provision for Income Taxes
The effective tax rate differs from the statutory U.S. federal income tax rate of 34% primarily due to foreign income tax and the valuation allowance against the Company’s domestic deferred tax assets.
We recorded a restated income tax provision of $416,000 for the third quarter of 2012 compared with an income tax provision of $922,000 for the same quarter in 2011. This provision is primarily related to taxes on income generated by our Swiss subsidiary. Unremitted earnings of foreign subsidiaries have been included in the consolidated financial statements without giving effect to the United States taxes that may be payable as it is not anticipated such earnings will be remitted to the United States. The Company has established a valuation allowance against its U.S. federal and state deferred tax assets, as well as the deferred tax asset of a foreign subsidiary, due to the uncertainty surrounding the realization of such assets as evidenced by the cumulative losses from operations through September 30, 2012. Management periodically evaluates the recoverability of the deferred tax assets and at such time as it is determined that it is more likely than not that deferred assets are realizable, the valuation allowance will be reduced accordingly.
The Nine Months Ended September 30, 2012 Compared with the Nine Months Ended September 30, 2011
The following table presents certain unaudited statement of operations data expressed as a percentage of revenue for the periods indicated:

37


 
 
Nine Months Ended
 
 
September 30,
 
 
2012
 
2011
 
 
(Restated)
 
(Restated)
Revenue
 
100
 %
 
100
 %
Cost of revenue
 
58
 %
 
61
 %
Gross profit
 
42
 %
 
39
 %
Operating expenses:
 
 
 
 
Selling, general and administrative
 
22
 %
 
24
 %
Research and development
 
14
 %
 
16
 %
Total operating expenses
 
36
 %
 
40
 %
Income (loss) from operations
 
6
 %
 
(1
)%
Interest expense, net
 
(1
)%
 
 %
Income from operations before income taxes
 
5
 %
 
(1
)%
Income tax provision
 
1
 %
 
1
 %
Net income (loss)
 
4
 %
 
(2
)%
Net income reported for the nine months ended September 30, 2012 was $4.3 million, or $0.15 per diluted share, compared with a net loss of $2.0 million, or $0.07 per diluted share, in the same period one year ago. The generation of net income compared with the net loss incurred in the prior year period was primarily driven by revenue growth, combined with improvements in gross profit and operating margins. Further, during the nine months ended September 30, 2011, we recorded an accrual of $2.6 million for the anticipated settlement of a legal matter with a customer as contra-revenue, and we recorded a settlement gain of $667,000 during the nine months ended September 30, 2012. In addition, during the nine months ended September 30, 2011, we recorded a gain on embedded derivatives and warrants of $1.1 million.
Revenue and Gross Profit
The following table presents a comparison of revenue, cost of revenue and gross profit for the nine months ended September 30, 2012 and 2011 (in thousands, except percentages):
 
 
Nine Months Ended
 
Nine Months Ended
 
 
 
 
 
 
September 30, 2012
 
September 30, 2011
 
 
 
 
 
 
(Restated)
 
(Restated)
 
 
 
 
 
 
Amount
 
% of
Revenue
 
Amount
 
% of
Revenue
 
Increase
 
%
Change
Revenue
 
$
114,755

 
100
%
 
$
109,800

 
100
%
 
$
4,955

 
5
 %
Cost of revenue
 
66,932

 
58
%
 
67,740

 
61
%
 
(808
)
 
(1
)%
Gross profit
 
$
47,823

 
42
%
 
$
42,060

 
39
%
 
$
5,763

 
14
 %
Revenue. In the nine months ended September 30, 2012, revenue increased 5% to $114.8 million, compared with $109.8 million in the same period one year ago. The increase in revenue was influenced primarily by higher revenues for our high voltage capacitor product line, which increased by $3.6 million for the first nine months of 2012 compared with the same period in the prior year. Revenues for our ultracapacitor product line increased by 1% compared with the same period in the prior year, however, we had recorded an accrual of $2.6 million for the anticipated settlement of a legal matter with a customer as contra-revenue during the nine months ended September 30, 2011, and we recorded a settlement gain of $667,000 as revenue during the nine months ended September 30, 2012; absent these factors, ultracapacitors revenues were down 4% period over period related to decreased demand in the hybrid transit vehicle market. Revenue for our microelectronics products, which tend to be volatile, increased by $592,000 for the nine months ended September 30, 2012.

38


Beginning in the fourth quarter of the year ended December 31, 2011, for sales to three distributors, we began recognizing revenue upon collection of the sales price, rather than upon shipment, due to certain arrangements with these distributors related to payment terms on sales. In addition, for one distributor, also beginning in the fourth quarter of the year ended December 31, 2011, due to return rights and profit margin protection given to the distributor, we began deferring revenue on all sales until such time as the distributor confirms with us that they are not entitled to any further returns or credits. As a result of these arrangements and other less significant arrangements requiring the deferral of revenue, for the nine months ended September 30, 2012, we deferred revenue recognition on $17.4 million in sales, and recognized $7.1 million of previously deferred revenue as revenue. For the nine months ended September 30, 2011, related to other less significant arrangements requiring the deferral of revenue as mentioned above, we deferred revenue recognition on $2.3 million in sales, and recognized $734,000 of previously deferred revenue as revenue.
Related to the one distributor that was given return rights and profit margin protection for which we have deferred revenue on all sales beginning in the fourth quarter of the year ended December 31, 2011, this revenue will remain deferred until such time as the distributor confirms with us that they are not entitled to any further returns or credits. At such time as this determination is made, which is currently anticipated to occur in the second half of the fiscal year 2013, previous sales for which revenue has been deferred, net of any credits or returns that may be made by the distributor, will be recognized as revenue. As of September 30, 2012, cumulative sales to this distributor for which revenue has not yet been recognized is $6.6 million.
A substantial amount of our revenue is generated through our Swiss subsidiary which has a functional currency of the Swiss Franc. As such, reported revenue can be materially impacted by the changes in exchange rates between the Swiss Franc and the U.S. Dollar, our reporting currency. Due to the strengthening of the U.S. Dollar against the Swiss Franc during the nine months ended September 30, 2012 compared with the same period one year ago, revenue was negatively impacted by $2.6 million.
Gross Profit. During the nine months ended September 30, 2012, gross profit increased $5.8 million or 14% compared with the same period in 2011. As a percentage of revenue, gross profit margin increased to 42% compared with 39% in the same period one year ago. Of the increase in gross profit in absolute dollars, $3.9 million was due to net reductions of product costs for both our ultracapacitor and high voltage product lines. In addition, there was an increase in gross profit in absolute dollars due to the classification as contra-revenue of a $2.6 million legal settlement accrual related to a customer dispute recorded in Q2 2011, as well as a settlement gain of $667,000 recorded in Q1 2012. Offsetting these increases was a decrease in gross profit in absolute dollars of $1.3 million related to the impact of changes in foreign currency exchange rates, primarily due to changes between the Swiss Franc and the U.S. Dollar.
Selling, General and Administrative Expense
The following table presents selling, general and administrative expense for the first nine months ended September 30, 2012 and 2011 (in thousands, except percentages):
 
 
 
Nine Months Ended
 
Nine Months Ended
 
 
 
 
 
 
September 30, 2012
 
September 30, 2011
 
 
 
 
 
 
(Restated)
 
(Restated)
 
 
 
 
 
 
Amount
 
% of
Revenue
 
Amount
 
% of
Revenue
 
Decrease
 
%
Change
Selling, general and administrative
 
$
25,539

 
22
%
 
$
26,759

 
24
%
 
$
(1,220
)
 
(5
)%
Selling, general and administrative expenses were 22% of revenue for the nine months ended September 30, 2012, down from 24% in the same period one year ago, while total selling, general and administrative expenses decreased by $1.2 million, or 5%. The decrease in absolute dollars was driven by a decrease in legal expenses of $1.4 million due to the resolution of certain legal matters. Further, there was a decrease of $1.0 million in bonus expense, which was primarily due to no bonus expense having been recorded for the nine months ended September 30, 2012 as the financial targets related to our 2012 bonus program will not likely be achieved. Offsetting these decreases, advertising costs increased by $782,000, and consulting costs increased by $411,000, primarily related to the roll out of a new ultracapacitor product, the Engine Start Module, as well as increased participation in trade shows and other advertising media.
Research and Development Expense
The following table presents research and development expense for the nine months ended September 30, 2012 and 2011 (in thousands, except percentages):
 

39


 
 
Nine Months Ended
 
 
 
 
 
 
 
 
September 30, 2012
 
Nine Months Ended
 
 
 
 
 
 
(Restated)
 
September 30, 2011
 
 
 
 
 
 
Amount
 
% of
Revenue
 
Amount
 
% of
Revenue
 
Decrease
 
%
Change
Research and development
 
$
15,948

 
14
%
 
$
16,976

 
16
%
 
$
(1,028
)
 
(6
)%
Research and development expenses were 14% of revenue for the nine months ended September 30, 2012, down from 16% in the same period one year ago, while total research and development expenses decreased by $1.0 million, or 6%. The decrease in absolute dollars was primarily driven by a $413,000 decrease in bonus expense, which was primarily due to no bonus expense having been recorded for the nine months ended September 30, 2012 as the financial targets related to our 2012 bonus program will not likely be achieved. In addition, salary and contract labor costs decreased by $532,000 primarily related to higher contract labor costs incurred in 2011 for the design of the Engine Start Module.
Gain on Embedded Derivatives
The Company recorded a gain on embedded derivatives of $1.1 million during the nine months ended September 30, 2011. The gain recorded on the embedded derivatives represents the change in the fair market value on revaluation of the debenture conversion rights at the conversion date compared with the beginning of the year. In February 2011, the remaining principal balance of the convertible debentures was converted to shares of our common stock. As such, there has been no further impact to the consolidated statement of operations related to the fair value measurement of these derivative instruments.
Provision for Income Taxes
The effective tax rate differs from the statutory U.S. federal income tax rate of 34% primarily due to foreign income tax and the valuation allowance against the Company’s domestic deferred tax assets.
We recorded a restated income tax provision of $1.8 million for the nine months ended September 30, 2012 compared with an income tax provisions of $1.2 million for the same period in 2011. During the nine months ended September 30, 2011, we recorded a tax benefit of $565,000 related to an accrual for the anticipated settlement of a legal matter by our Swiss subsidiary. Excluding this impact, we recorded a tax provision of $1.8 million related to income generated by our Swiss subsidiary for the nine months ended September 30, 2011, compared with a tax provision of $1.8 million for the nine months ended September 30, 2012. Unremitted earnings of foreign subsidiaries have been included in the consolidated financial statements without giving effect to the United States taxes that may be payable as it is not anticipated such earnings will be remitted to the United States. The Company has established a valuation allowance against its U.S. federal and state deferred tax assets, as well as the deferred tax asset of a foreign subsidiary, due to the uncertainty surrounding the realization of such assets as evidenced by the cumulative losses from operations through September 30, 2012. Management periodically evaluates the recoverability of the deferred tax assets and at such time as it is determined that it is more likely than not that deferred assets are realizable, the valuation allowance will be reduced accordingly.
Liquidity and Capital Resources
Changes in Cash Flow
The following table summarizes our cash flows from operating, investing and financing activities for the nine months ended September 30, 2012 and 2011 (in thousands): 
 
 
Nine months ended September 30,
 
 
2012
 
2011
 
 
(Restated)
 
(Restated)
Total cash provided by (used in):
 
 
 
 
Operating activities
 
$
(11,593
)
 
$
(6,821
)
Investing activities
 
(13,121
)
 
(10,994
)
Financing activities
 
16,041

 
10,200

Effect of exchange rate changes on cash and cash equivalents
 
(543
)
 
(1,226
)
Decrease in cash and cash equivalents
 
$
(9,216
)
 
$
(8,841
)
Net cash used in operating activities was $11.6 million for the nine months ended September 30, 2012. This usage of cash related primarily to an increase in accounts receivable of $10.8 million, an increase in inventories of $10.6 million, as well

40


as settlement payments of $5.1 million related to the Foreign Corrupt Practices Act matter. The increase in accounts receivable was due to significant sales in the last month of the quarter, as well as slow payment from several customers. The increase in inventories is primarily related to an increase in consigned inventory located at distributors, as we deferred revenue recognition on sales to certain distributors beginning in the fourth quarter of 2011. Offsetting these decreases in cash, during the nine months ended September 30, 2012, we generated net income, net of non-cash items, of $12.4 million. Net cash used in operating activities was $6.8 million for the nine months ended September 30, 2011, which related primarily to increase in inventories associated with growth in our business, as well as settlement payments of $6.7 million related to the Foreign Corrupt Practices Act matter.
Net cash used in investing activities was $13.1 million and $11.0 million for the nine months ended September 30, 2012 and 2011, respectively, and related to capital expenditures. Capital expenditures in the nine months ended September 30, 2012 were primarily focused on investments in increased production capacity, including equipment for our new manufacturing facility in Peoria, Arizona, and our corporate research and development facility in San Diego, California. In 2011, capital expenditures were primarily focused on investments in our corporate research and development facility, information technology infrastructure and increased production capacity.
Net cash provided by financing activities was $16.0 million and $10.2 million for the nine months ended September 30, 2012 and 2011, respectively. Net cash provided by financing activities in the nine months ended September 30, 2012 primarily resulted from net proceeds from the sale of common stock of $10.3 million, net borrowings of $4.3 million and proceeds from the issuance of common stock under our stock-based compensation plans of $1.7 million. Net cash provided by financing activities in the nine months ended September 30, 2011 primarily resulted from proceeds from the issuance of common stock under our stock-based compensation plans of $2.6 million, as well as the release of $8.0 million in restricted cash upon the settlement of the remaining principal balance of our convertible debentures.
Liquidity
As of September 30, 2012, we had approximately $20.1 million in cash and cash equivalents, and working capital of $52.9 million. Although we have a credit facility providing for a $15.0 million line of credit which has not been drawn upon to date, based on the events of default discussed below as a result of our restatement of previously issued financial statements, the bank's obligation to extend any further credit ceased and terminated subsequent to September 30, 2012. We currently owe $4.5 million under the equipment term loan provided by the same credit facility. In June 2013, we entered into a forbearance agreement with the bank wherein the bank agreed to forbear from further exercise of its rights and remedies to call our outstanding debt under the credit agreement in connection with the events of default for a period terminating on the earlier of September 30, 2013 or the occurrence of any additional events of default.
In April 2011, we filed a shelf registration statement on Form S-3 with the SEC to, from time to time, sell up to an aggregate of $125 million of our common stock, warrants or debt securities. During the quarter ended March 31, 2012, we sold a total of 572,510 shares of our common stock for net proceeds of $10.3 million pursuant an At-the-Market Equity Offering Sales Agreement (“Sales Agreement”) with Citadel Securities LLC (“Citadel”) dated February 2012. Since then we have not sold any further shares under this program. As a result of the restatement of previously issued financial statements as discussed in Note 2 to our consolidated financial statements in this report, beginning in March 2013, we are no longer in compliance with the ongoing eligibility requirements of this shelf registration statement on Form S-3. Therefore, the shelf registration statement is no longer effective and no further securities may be issued pursuant to this registration statement.
Management believes that the cash we expect to generate from operations, combined with available cash balances, will be sufficient to fund our operations, obligations as they become due, and capital equipment expenditures for at least the next twelve months. In addition, we may choose to issue additional debt or equity to supplement our existing cash balances and cash from operating activities.
As of September 30, 2012, we have an accrual recorded in the amount of $2.3 million for the remaining settlement payment to be made in connection with past FCPA violations, which is payable in the first quarter of 2013. In addition, we have an accrual of 739,000 Euro ($949,000 as of September 30, 2012) for the remaining consideration due as a result of settlement of a past customer dispute, which is available to the customer as a discount on purchases of our products through December 31, 2014. Any balance of this original, non-cash settlement value of 1.3 million Euro not used as product discount by December 31, 2014 will be payable in cash at that time.
As of September 30, 2012, the amount of cash and short-term investments held by foreign subsidiaries was $12.9 million. If these funds are needed for our operations in the U.S. in the future, we may be required to accrue and pay taxes to repatriate these funds at a rate of approximately 5%.

41


Credit Facility
In December 2011, we entered into a credit agreement whereby we obtained a secured credit facility in the form of a revolving line of credit up to a maximum of $15.0 million (the “Revolving Line of Credit”) and an equipment term loan (the “Equipment Term Loan”) (together, the “Credit Facility”). In general, amounts borrowed under the Credit Facility are secured by a lien on all of our assets other than our intellectual property. In addition, under the credit agreement, we are required to pledge 65% of our equity interests in our Swiss subsidiary. We have also agreed not to encumber any of our intellectual property. The agreement contains certain restrictive covenants that limit our ability to, amongst other things; (i) incur additional indebtedness or guarantees; (ii) create liens or other encumbrances on our property; (iii) enter into a merger or similar transaction; (iv) invest in another entity; (v) declare or pay dividends; and (vi) invest in fixed assets in excess of a defined dollar amount. Repayment of amounts owed pursuant to the Credit Facility may be accelerated in the event that we are in violation of the representations, warranties and covenants made in the credit agreement, including certain financial covenants. The financial covenants that we must meet during the term of the credit agreement include quarterly minimum liquidity ratios, minimum quick ratios and EBITDA targets and an annual net income target. Borrowings under the Credit Facility bear interest, payable monthly, at either (i) the bank's prime rate or (ii) LIBOR plus 2.25%, at our option subject to certain limitations. Further, we incur an unused commitment fee, payable quarterly, equal to 0.25% per annum of the average daily unused amount of the Revolving Line of Credit.
The Equipment Term Loan was available to finance 80% of eligible equipment purchases made between April 1, 2011 and April 30, 2012. During this period, we borrowed $5.0 million under the Equipment Term Loan.
As a result of the restatement of prior period financial statements, as such financial information was previously submitted to the bank has since proven to be materially incorrect, we were in default with respect to the terms of the credit agreement beginning in the fourth quarter of 2011. In addition, as a result of the restatement of these prior period financial statements, we were not in compliance with the financial covenant pertaining to the annual minimum net income target for the fiscal year ended December 31, 2011. Although, we did meet the financial covenants of the credit agreement in all other periods since the Credit Facility was entered into, including as of December 31, 2012, these violations represent events of default under the terms of the Credit Facility, and as a result of this noncompliance, the bank's obligation to extend any further credit has ceased and terminated.
In June 2013, we entered into a forbearance agreement with the bank (“the Forbearance Agreement”). Pursuant to the terms of the Forbearance Agreement, the bank agreed to forbear from further exercise of its rights and remedies under the credit agreement to call our outstanding debt obligation in connection with the events of default for a period terminating on the earlier of September 30, 2013 or the occurrence of any additional events of default. In connection with the execution of the Forbearance Agreement, in June 2013, we posted a cash deposit of $1.8 million with the bank and granted the bank a security interest therein, which will remain restricted until the bank may determine to waive the existing events of defaults discussed above, or the loan is satisfied.
As of September 30, 2012, $4.5 million was outstanding under the Equipment Term Loan and the applicable interest rate was LIBOR plus 2.25% (2.5% as of September 30, 2012). If the bank does not exercise its right to accelerate repayment, under the original terms of the Credit Facility, principal and interest under the Equipment Term Loan are payable in 36 equal monthly installments such that the Equipment Term Loan is fully repaid by the maturity date of April 30, 2015, but may be prepaid in whole or in part at any time. As of September 30, 2012, no amounts were outstanding under the Revolving Line of Credit. Since September 30, 2012, the Company has not made any additional borrowings on the Equipment Term Loan or the Revolving Line of Credit, and as a result of the events of default discussed above, the Company is currently not eligible to borrow any additional amounts under the Credit Facility.
Short-term and Long-term Borrowings
Short-term borrowings
Maxwell’s Swiss subsidiary, Maxwell SA, has a 3.0 million Swiss Franc-denominated (approximately $3.2 million as of September 30, 2012) credit agreement with a Swiss bank, which renews semi-annually and bears interest at 2.2%. Borrowings under the short-term loan agreement are unsecured and as of September 30, 2012 and December 31, 2011, the full amount of the loan was drawn.
Maxwell SA also has a 2.0 million Swiss Franc-denominated (approximately $2.1 million as of September 30, 2012) credit agreement with a Swiss bank, which renews annually and bears interest at 2.4%. Borrowings under the credit agreement are unsecured and as of September 30, 2012 and December 31, 2011, the full amount available under the credit line was drawn.
Maxwell SA also has a 1.0 million Swiss Franc-denominated (approximately $1.1 million as of September 30, 2012) credit agreement with another Swiss bank, and the available balance of the line can be withdrawn or reduced by the bank at any

42


time. As of September 30, 2012 and December 31, 2011, no amounts were drawn under the credit line. Interest rates applicable to any draws on the line will be determined at the time of draw.
Long-term borrowings
The Company has various financing agreements for vehicles. These agreements are for up to a five year repayment period with interest rates ranging from 4.9% to 7.0%. At September 30, 2012 and December 31, 2011, $77,000 and $164,000, respectively, was outstanding under these financing agreements.
Critical Accounting Policies and Estimates
In our Annual Report on Form 10-K for the fiscal year ended December 31, 2012 filed on August 1, 2013, we restated our financial statements for the first three quarters of the fiscal year ended December 31, 2012, for the fiscal year ended December 31, 2011, and for each of the interim periods within the fiscal year ended December 31, 2011. The restatement resulted in changes to our critical accounting policies and estimates for the restated periods. As a result, for a description of our significant accounting policies, refer to Note 1, Description of Business and Summary of Significant Accounting Policies, of the notes to consolidated financial statements included in our Annual Report on Form 10-K for the fiscal year ended December 31, 2012. For a discussion of our critical accounting estimates, refer to Item 7, Management’s Discussion and Analysis of Financial Condition and Results of Operations, in our Annual Report on Form 10-K for the fiscal year ended December 31, 2012. There are no significant differences in our significant accounting policies or critical accounting estimates as of September 30, 2012 compared with December 31, 2012.
Off Balance Sheet Arrangements
None.

Item 3.
Quantitative and Qualitative Disclosures about Market Risk
We face exposure to financial market risks, including adverse movements in foreign currency exchange rates and changes in interest rates. These exposures may change over time and could have a material adverse impact on our financial results. We have not entered into or invested in any instruments that are subject to market risk, except as follows:
Foreign Currency Risk
Our primary foreign currency exposure is related to our subsidiary in Switzerland. Maxwell SA has Euro and local currency (Swiss Franc) revenue and operating expenses, as well as local currency loans. Changes in these currency exchange rates impact the reported amount (U.S. dollar) of revenue, expenses and debt. As part of our risk management strategy, we use forward contracts to hedge certain foreign currency exposures. Our objective is to offset gains and losses resulting from these exposures with gains and losses on the forward contracts, thereby reducing volatility of earnings. We use the forward contracts to hedge certain monetary assets and liabilities, primarily receivables and payables, denominated in a foreign currency. The change in fair value of these instruments represents a natural hedge as their gains and losses offset the changes in the underlying fair value of the monetary assets and liabilities due to movements in currency exchange rates. We enter into these foreign currency forward contracts on the last business day of each calendar quarter, therefore, as of September 30, 2012, the impact of any theoretical change in foreign currency exchange rates on the hedged monetary assets and liabilities would be equally offset by the theoretical gains and losses on the foreign currency forward contracts. In addition, our Swiss pension plan maintains certain plan investments in the Euro currency and changes in currency rates impact the reported amount of our net pension asset.
Fair Value Risk
We had a net pension asset of $6.9 million and $6.4 million at September 30, 2012 and December 31, 2011, respectively. As of the last fair value measurement date of December 31, 2011, the net pension asset included plan assets with a fair value of $33.1 million. The plan assets consisted of 86% debt and equity securities, 12% real estate and 2% cash and cash equivalents. The fair value measurement of the real estate is subject to the real estate market forces in Switzerland. The fair values of debt and equity securities are determined based on quoted prices in active markets for identical assets and are subject to interest rate risk. We manage our risk by having a diversified portfolio.

Item 4.
Controls and Procedures
Background

43


As discussed in Note 2, Restatement of Previously Issued Financial Statements, of the Notes to Consolidated Financial Statements included in Part I—Item 1, Financial Statements, the Audit Committee in consultation with management and the Board of Directors, in March 2013, concluded that the Company’s previously issued financial statements for the fiscal year ended December 31, 2011 and the first three quarters of fiscal year 2012 should no longer be relied upon. Accordingly, the Company restated its previously issued financial statements for those periods within its annual report on Form 10-K for the year ended December 31, 2012. See Note 2, Restatement of Previously Issued Financial Statements, of the Notes to Consolidated Financial Statements included in Part I—Item 1, Financial Statements, Item 2, Management’s Discussion and Analysis of Financial Condition and Results of Operations—Background on the Restatement, and and Supplementary Data.
Evaluation of Disclosure Controls and Procedures
We are committed to maintaining disclosure controls and procedures designed to ensure that information required to be disclosed in our periodic reports filed under the Securities and Exchange Act of 1934 (the “Exchange Act”) is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our Principal Executive Officer and Principal Financial Officer, as appropriate, to allow for timely decisions regarding required disclosure.
Under the supervision and with the participation of our management, including our Principal Executive Officer and Principal Financial Officer, we conducted an evaluation of the effectiveness of the design and operation of our disclosure controls and procedures as of September 30, 2012, as such term is defined under Rule 13a-15(e) promulgated under the Exchange Act. Based on this evaluation, our Principal Executive Officer and Principal Financial Officer concluded that our disclosure controls and procedures were not effective as of the end of the period covered by this Quarterly Report on Form 10-Q/A, because of the material weaknesses in internal control over financial reporting discussed below.
Material Weaknesses
A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of our annual or interim financial statements will not be prevented or detected on a timely basis.
For certain sales transactions, sales and other personnel have entered into side arrangements with customers for return rights, extended payment terms, profit margin protection and transfer of title terms that were not communicated to the finance and accounting department, or to our CEO. As such, we did not maintain effective controls over our revenues and accounts receivable balances as the sales price was not fixed or determinable nor was collectability reasonably assured at the time revenue was originally recognized. As a result, we recognized revenue prematurely. These errors resulted in the restatement of our consolidated financial statements for each of the previously reported interim and annual periods within the fiscal years ended December 31, 2012 and 2011. These control deficiencies could result in misstatements of revenue and accounts receivable balances and related disclosures that would result in material misstatement of the consolidated financial statements that would not be prevented or detected. Accordingly, our management has determined that each of these control deficiencies constitutes a material weakness. The specific material weaknesses are:
we did not maintain adequately designed controls to ensure accurate recognition of revenue in accordance with GAAP. Specifically, controls were not effective to ensure that deviations from contractually established sales terms were authorized, communicated, identified and evaluated for their potential effect on revenue recognition. Further, we did not adequately train and supervise sales personnel to ensure that such personnel were appropriately conscious of the requirement to communicate deviations from contractually established sales terms to finance and accounting personnel in order for revenue recognition in our financial statements to be accurately recorded; and,
We did not perform a robust fraud risk assessment taking into consideration the various ways that fraud may be perpetrated to misappropriate assets or facilitate fraudulent financial reporting.  We failed to identify controls specifically designed to prevent and detect fraud risks relating to revenue recognition.
Remediation Plan
We are in the process of developing a plan for remediation of the above material weaknesses and plan to undertake the following initiatives:
improve procedures to ensure the proper communication, approval and accounting review of deviations from sales contracts, and provide periodic training and a formal revenue recognition policy to sales personnel and others involved in negotiating contractual sales terms, in order to improve awareness and understanding of revenue recognition principles under GAAP; and,

44


implement an improved fraud risk assessment process to consider specific ways in which asset misappropriation or fraudulent financial reporting might occur and ensure controls are identified to address the risk of fraud.
Management is committed to a strong internal control environment and believes that, when fully implemented and tested, the measures described above will improve our internal control over financial reporting. We will continue to assess the effectiveness of our remediation efforts in connection with our future assessments of the effectiveness of internal control over financial reporting.
Changes in Internal Control Over Financial Reporting
There have been no changes in our internal control over financial reporting during the quarter ended September 30, 2012 that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.


45


PART II – OTHER INFORMATION
 
Item 1.
Legal Proceedings
The information set forth under Note 11 of Notes to Unaudited Condensed Consolidated Financial Statements, included in Part I, Item 1 of this report, is incorporated herein by reference.

Item 1A.
Risk Factors
There have been no material changes from the risk factors disclosed in Part I, Item 1A, of the Company’s Annual Report on Form 10-K for the fiscal year ended December 31, 2012 filed on August 1, 2013, which are incorporated herein by reference.

Item 2, 3, 4 and 5 are not applicable and have been omitted.


Item 6.
Exhibits
31.1
  
Certification of Principal Executive Officer pursuant to Rule 13a-14(a) (Section 302 Certification) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. *
 
 
 
31.2
  
Certification of Principal Financial Officer pursuant to Rule 13a-14(a) (Section 302 Certification) as adopted pursuant to Section 302 of the Sarbanes-Oxley Act of 2002. *
 
 
 
32
  
Certification of Principal Executive Officer and Principal Financial Officer pursuant to 18 U.S.C. Section 1350 (Section 906 Certification), as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. *
 
 
 
101
  
The following financial statements and footnotes from the Maxwell Technologies, Inc. Quarterly Report on Form 10-Q/A for the quarter ended September 30, 2012 formatted in Extensible Business Reporting Language (XBRL): (i) Condensed Consolidated Balance Sheets; (ii) Condensed Consolidated Statements of Operations; (iii) Condensed Consolidated Statements of Comprehensive Income (Loss) (iv) Condensed Consolidated Statements of Cash Flows; and (v) the Notes to Condensed Consolidated Financial Statements. **
 
*
Filed herewith.
**
Furnished herewith.



46


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
 
 
MAXWELL TECHNOLOGIES, INC.
 
 
 
 
 
Date:
August 13, 2013
 
By:
/s/ David J. Schramm
 
 
 
 
David J. Schramm
 
 
 
 
President and Chief Executive Officer
 
 
 
 
 
Date:
August 13, 2013
 
By:
/s/ Kevin S. Royal
 
 
 
 
Kevin S. Royal
 
 
 
 
Senior Vice President, Chief Financial Officer, Treasurer and Secretary

47